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Abstract 
  Epigenetic regulation of gene expression is essential for faithful cellular specification 
during embryonic development. Directed differentiation of pluripotent human embryonic stem 
cells (hESCs), which maintain the ability to give rise to each cell type found within the human 
body, provides a tractable system to study both the epigenetic mechanisms that facilitate cellular 
transitions, and the transcription factors (TFs) that dictate these events. To understand molecular 
events associated with major lineage decisions, we performed comprehensive genomic profiling, 
including  RNA-Sequencing,  Chromatin  Immunoprecipitation-Sequencing  (ChIP-Seq)  for  six 
histone  modifications  and  whole  genome  bisulfite-sequencing  (WGBS)  to  interrogate  DNA 
methylation  levels,  on  three  populations  derived  through  directed  differentiation  of  hESCs. 
Expression profiling detected signatures that resembled the three embryonic germ layers, namely 
ectoderm,  mesoderm  and  endoderm.  Integration  of  ChIP-Seq  and  WGBS  data  revealed 
widespread remodeling, predominantly at intergenic regions. To understand the impact of TF 
binding  on  epigenetic  remodeling,  we  then  complemented  the  epigenetic  information  with 
binding profiles for the pluripotency TFs OCT4, SOX2 and NANOG (O/S/N) in hESCs, and 
FOXA2 in the endoderm population. O/S/N binding was identified near pluripotency genes as 
expected, as well as regions that exhibited lineage specific remodeling during differentiation and 
are linked to later stages of development. We also discerned a novel epigenetic trend, in which 
H3K27me3 was unexpectedly gained at regions of low CpG density that exhibit high levels of 
DNA methylation in hESCs. These events overlapped with FOXA2 binding sites in the dEN that 	 ﾠ iv	 ﾠ
lose DNA methylation. Notably, these events were detected near genes associated with later 
stages  of  development,  such  as  AFP.  We  postulate  that  these  FOXA2-associated  epigenetic 
remodeling events lead to acquisition of a transient, facultative heterochromatic state necessary 
to foster efficient differentiation of subsequent stages. Integration of these data sets yielded an 
unprecedented perspective of the orchestrated transcriptional and epigenetic events that occur 
during cell state transitions. Future studies that compare epigenomic profiles of in vitro derived 
cell  types  to  their  primary  counterparts  may  identify  regulatory  elements  that  are  held  in 
improper epigenetic states, and ultimately lead to improved differentiation protocols and the in 
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1.1 Introduction 
  The inner cell mass (ICM) of a blastocyst has the unique ability to give rise to any cell 
type found within the embryo proper [2]. This is possible due to the molecular plasticity of the 
pluripotent state, a feature that is gradually lost as a cell becomes specialized during embryonic 
development [3, 4]. The specification of embryonic lineages from the ICM is the result of a 
combination of intrinsic and exogenous stimuli, which leads to cells assuming the identity of one 
the three embryonic germ layers: ectoderm, mesoderm and endoderm [5].   
Coordinated and timely propagation of epigenetic information, such as DNA methylation 
and the post-translational modification of histone proteins, cooperates with other mechanisms to 
guide cells along the path of lineage specification [6]. The term “epigenetic landscape,” was 
coined to illustrate the concept that a cell’s early choice of lineage dictates its future, as 
epigenetic mechanisms prevent lineage interconversion in vivo, leading to the gradual restriction 
of cell fate [2]. The derivation of human embryonic stem cells (hESCs) offered an exciting 
avenue to study these epigenetic decisions that dictate specification in a human context, as 
hESCs maintain the ability to differentiate towards the three embryonic germ layers in vitro [7]. 
This robust model system therefore creates a platform with which to study the epigenetic choices 
that promote cellular determination.     
 
1.2 Epigenetic Regulation: DNA methylation 
  The term DNA methylation refers to cytosines that contain a methyl group on carbon 5, 
with the majority of DNA methylation occurring in a CG (CpG) dinucleotide context [8]. 
Throughout the human and mouse genome, 1 CpG is typically found every 100 base pairs (bp), 
and ≈80% of CpGs contain methylation in any given cell type [9-12]. Alternatively, CpG islands 	 ﾠ 3	 ﾠ
(CGI) contain approximately 1 CpG every 10 bp and are typically void of DNA methylation [13]. 
They are found at 60% of human transcription start sites (TSS), and frequently overlap regions 
associated with embryonic transcription factors (TF) [13, 14]. The inclusion of a methylated 
cytosine within a regulatory element can prevent TFs from binding to DNA in some scenarios, 
which in turn limits transcription at that locus [1, 15]. Therefore, DNA methylation at certain 
regulatory elements is considered a stable form of gene repression, as it is prevalent in somatic 
cells at regulatory elements employed during embryonic development [8]. It is also involved in 
silencing regions associated with alternative lineages, that are presumably not required for 
maintenance of the specified somatic cellular identity exhibiting the DNA methylation [16]. In 
addition to its role in the regulation at specific genes, DNA methylation is also required for 
genomic stability, as disruption of DNA methylation patterns leads to aberrant chromosome 
segregation [17].  
  The addition of the methyl group is catalyzed by one of the three active DNA 
methyltransferases; DNMT1 [18], DNMT3a, or DNMT3b [19]. DNMT1 is generally responsible 
for copying the methylation pattern from the parent strand to the daughter strand during DNA 
replication [18], while DNMT3A/B exhibit de novo activity during cellular transitions [19, 20]. 
The deletion of DNMT3A/B results in embryonic lethality, suggesting that propagation of DNA 
methylation is essential for cellular specification [20]. Many reports have established that 
DNMT3A/B are responsible for DNA methylation at regions of genomic imprinting and satellite 
repeats [21-24], but the factor(s) responsible for catalyzing addition at specific gene regulatory 
elements during lineage specification and the timing of these events are not well defined [25]. 
CpG methylation must also be eliminated from regulatory elements, to alleviate 
repression and allow embryonic development to proceed. Recent studies indicated TF binding 	 ﾠ 4	 ﾠ
and high DNA methylation tend to be mutually exclusive events [10, 11, 26], although the 
mechanism that induces the discrete loss during development remains somewhat elusive [27]. 
Recent identification of the TET enzymes, which catalyze the oxidation of 5-methylcytosine 
(5mC) to 5-hydroxymethylcytosine (5hmC) [28, 29], reveals a potential mechanism for DNA 
demethylation because DNMT1 does not recognize 5hmC [30].  
 
1.3 Epigenetic Regulation: Histone Modifications 
Nucleosomes, which consist of an octamer of histone proteins, provide another layer of 
epigenetic regulation of gene expression [31]. Post-translational modifications to the histone N-
terminal tails, such as acetylation and methylation, have been reported for each histone [32]. 
These modifications regulate gene expression by affecting nucleosome organization within the 
nucleus, as well as polymerase II (Pol II) elongation during transcription [33, 34]. Histone lysine 
acetylation was one of the first post-translational modifications extensively studied [35], because 
early studies aimed at understanding the mechanism by which sodium butyrate induces cellular 
transitions found it led to acetylation of H3 and H4 [36, 37]. This modification was shown to 
prevent chromatin compaction [38], and its discrete localization was associated with gene 
expression [39].  
With evidence that histone acetylation was essential for gene regulation, studies then 
focused on substrate specificity of histone acetyltransferases (HATs) to understand if acetylation 
was randomly distributed throughout the histone protein. Studies in yeast and drosophila 
confirmed that it was non-random, and that HATs target specific residues [40, 41]. For example, 
H3K27ac is a commonly studied histone modification, which demarcates a subset of active 
promoters and enhancers [42, 43].  	 ﾠ 5	 ﾠ
Numerous subsequent studies devised to understand gene regulation via histone 
modifications suggested that multiple histones/residues/modifications need to be considered in 
tandem to infer regulatory impact of the surrounding chromatin landscape [44]. Additional 
consideration must be given to modifications such as lysine methylation, which correlate both 
with, and against transcriptional activity according to ChIP-Sequencing (ChIP-Seq) studies that 
established genome-wide maps of histone modifications [45]. A repressive role was reported for 
H3K9me3 and H3K27me3, which were enriched at various loci known to exist in a closed or 
heterochromatic state, such as centromeres, repeat elements and the inactivated X chromosome 
[46]. H3K9 methylation is most commonly associated with repeat elements, but promoter 
association was revealed by studying the correlation between DNA hypermethylation and cancer 
[47, 48]. Gene silencing mediated by H3K27me3 [46] is alternatively associated with regions of 
high CpG density [49]. Addition of H3K27me3 by the Polycomb repressive complex (PRC2) 
mediates repression by promoting a compact chromatin structure [50, 51]. 
A divergent role was reported for lysine methylation, as H3K4me was first associated 
with active transcription in Saccaromyces cerevisiae [52], and then extended to vertebrates [53]. 
Association with distinct genomic features was also reported as H3K4me3 was found at 
promoters while H3K4me1 was enriched at distal enhancers [23, 52, 54]. At promoters, 
H3K4me3 allows recruitment of nucleosome remodeling enzymes and HATs, which together 
create chromatin architecture amenable to transcription initiation [55-57]. H3K4 methylation is 
catalyzed by SET-domain containing histone methyltransferases (HMT), which maintain an 
opposing function to PRC2 [58]. Disruption of various SET domain containing-complex subunits 
causes severe embryonic defects and prevents efficient differentiation of mESCs in vitro [59-61]. 
Marks such as H3K36me3 and H3K79me3 are also associated with active transcription, but they 	 ﾠ 6	 ﾠ
are enriched over actively transcribed gene bodies [49, 62]. In conclusion, histone methylation is 
utilized in various contexts.  
 
1.4 Integration of Epigenetic Mechanisms 
Our ability to assess the regulatory function of epigenetic mechanisms was vastly 
improved with the creation of sequencing-based approaches. Rather than being limited to the 
interrogation of a few specific loci, sequencing provided a genome-wide enrichment profile for 
the protein or modification of interest. As more genome-wide studies were conducted, the 
relationships between coexisting epigenetic mechanisms and expression were defined, and are 
now commonly referred to as epigenetic states [42]. For example, it is now understood that some 
histone modifications maintain a mutually exclusive relationship with DNA methylation, such as 
H3K4me3 and H3K27me3 [14, 63]. This is supported by in vitro experiments that showed 
Dnmt3a activity was stimulated by an unmethylated H3 tail [64]. Though a positive correlation is 
exhibited between DNA methylation and Suv39h, a HMT that catalyzes H3K9me3 [48]. DNA 
methylation maintenance at pericentric satellite repeats required this HMT, and it reportedly 
interacts with all three of the DNMTs [23, 48, 65]. Gain of DNA methylation at the OCT4 
promoter during differentiation also requires G9a, another H3K9me3 HMTase, to promote 
DNMT3A/B-directed stable silencing [66, 67]. Expression of OCT4 decreases with the addition 
of H3K9me3 in this study, which suggests DNA methylation serves as a secondary form of 
silencing. DNA methylation is also found in concert with H3K36me3 over actively transcribed 
gene bodies, but DNA methylation appears to be propagated independent of H3K36me3 
enrichment given that depletion of SETD2, a H3K36me3 HMT, did not alter DNA methylation 
levels over gene bodies [68].  	 ﾠ 7	 ﾠ
The cooperation between multiple histone modifications became a major topic of interest 
with the observation that H3K27me3 and H3K4me3 were commonly found at regions of high 
CpG density in ESCs that were near regulators of embryonic development, and termed a bivalent 
domain [69, 70]. It was hypothesized that this combination facilitates swift activation during 
specification [71]. Similar to bivalent promoters, the combination of H3K4me1 was enriched 
with H3K27me3 at putative distal regulatory elements associated with transcriptional silencing, 
and termed poised domains [43, 72]. These elements were reported to then transition during 
development to include H3K27ac enrichment rather than H3K27me3, in addition to H3K4me1 
localization when the regulatory element was activated [43].  
While these studies suggested genomic overlap of histone modifications, some technical 
limitations originally prevented more discrete conclusions regarding the extent of the co-
occurrence. It was difficult to distinguish if these modifications occurred on different alleles 
leading to their putative overlap in the maps. Similarly, it was unclear if they occurred on the 
same nucleosome, which includes two molecules of each histone protein. It also remained 
possible that heterogeneity existed within the population, and the co-enrichment did not occur in 
one cell. More recent studies revealed that H3K4me3 and H3K27me3 do not coexist on the same 
histone tail but can occur on different H3 tails in one nucleosome [73]. This correlated with 
earlier work suggesting PRC2 activity is inhibited by the presence of H3K4 methylation [74].  
Our understanding of the interplay between DNA methylation and DNA-protein 
interactions also improved dramatically with the advent of whole genome bisulfite sequencing 
(WGBS), which allowed the interrogation of most CpG dinucleotides encoded within a genome 
[10, 11]. Integrating this data with histone modification and protein binding maps revealed 
regions of low DNA methylation at intergenic sites that frequently overlapped with DNaseI 	 ﾠ 8	 ﾠ
hypersensitivity (DHS), a symbol of open or accessible chromatin, and/or displayed an active 
enhancer signature defined by H3K4me1 and p300 enrichment [11]. A localized depletion of 
DNA methylation was also detected at regions of TF binding [10, 11], though the factors that 
catalyze this depletion at these sites was not fully elucidated.  
WGBS sequencing also confirmed a notable characteristic of the stem cell methylome; 
non-CpG methylation. DNA methylation presumed to be of regulatory significance is commonly 
studied in the CpG context, given historical studies that suggested greater than 90% of 
methylcytosine was detected in this context [9]. But profiling of mESCs initially revealed that 
CpA methylation was also prevalent, and likely catalyzed by DNMT3A [75]. Many years later, 
WGBS confirmed that CpA methylation was detectable in mESCS and hESCs, and also found 
that depletion of DNMT3A reduced the levels of CpA methylation in hESCs [10, 11, 76, 77]. 
More recent reports of WGBS from many stages of neural development also reported non-CpG 
methylation in the frontal cortex, which correlated with reactivation of DNMT3A expression [77, 
78].  
 
1.5 Directing Epigenetic Remodeling 
While sequencing-based studies established that histone modifications exhibit discrete 
localization, the mechanisms involved in targeting the addition and removal of histone 
methylation at specific genomic loci during cellular transitions remain somewhat unclear. It has 
been suggested that the CxxC finger protein CFP1 directs SET1 to promoters leading to 
enrichment of H3K4 methylation [79], which supports gene activation. An additional report 
suggested the TF USF1 recruits SET1A to genomic regions, which stimulated activation of target 	 ﾠ 9	 ﾠ
genes during differentiation [80]. But the factors responsible for widespread recruitment of 
HMTs to genomic locations during specification are mostly unknown.  
The mechanism of recruitment of complexes that catalyze the addition of repressive 
histone modifications is similarly unresolved in higher eukaryotes. While the Drosophila 
melanogaster genome encodes polycomb recruitment elements (PREs), which are responsible 
for recruiting the PRC2 complex to specific genomic sites to maintain silencing [81], similar 
sequences have been more difficult to find in mammals. As previously mentioned, H3K27me3 is 
associated with regions of high CpG density in vertebrates, but the additional underlying 
sequence context that recruits PRC2 to these regions genome-wide is an area under heavy 
investigation. In an attempt to understand PRC2 recruitment, an activating TF motif was deleted 
from an ectopic reporter sequence with a high GC content. This deletion lead to loss of the 
activating modification H3K4me3 and gain of H3K27me3 in mESCs [82], suggesting that in the 
absence of an activating TF that recruits HMTs to catalyze addition of a histone modification 
such as H3K4 methylation, H3K27me3 is gained by default. A subsequent study examined 
H3K27me3 dynamics during murine neural progenitor cell (NPC) differentiation, and found that 
inclusion of CoREST and SNAIL binding sites in an ectopic reporter also lead to high 
H3K27me3 enrichment [83]. Many studies, like those highlighted here, that attempted to 
establish recruitment mechanisms focused on a small number of loci or cell types, therefore this 
area of epigenetic regulation of gene expression requires further investigation.  
 
1.6 Signaling Pathways Associated with Chromatin Remodeling 
  Numerous signaling cascades converge on the nucleus during development to direct 
epigenetic remodeling that influences transcriptional regulation. For example, proper TGFβ 	 ﾠ 10	 ﾠ
signaling gradients are essential for cellular viability and differentiation [84]. Activation of 
TGFβ receptors located at the cell surface catalyzes a phosphorylation cascade that leads to 
SMAD protein interactions in the cytoplasm and their subsequent relocation to the nucleus [85]. 
Interestingly, high cell density of various cell lines prevented SMAD translocation to the nucleus 
in vitro, suggesting extrinsic factors in addition to morphogen gradients that may contribute to 
TGFβ signaling [86].  
  The SMAD1/5/8 complex is activated via BMP GDF ligands, while Activin/NODAL-
associated SMAD2/3 complex [87, 88]. Once transported inside the nucleus, the SMAD complex 
interacts with additional transcription factors to bind the SMAD DNA binding element and 
activate target gene expression [89]. Work in X. laevis showed that the SMAD2/3 complex 
interacts with Mix and FoxO family transcription factors to activate genes such as GSC and p21 
[90, 91]. This complex activates gene expression by recruiting the HAT p300 and Brg1 to target 
loci [92]. The SMAD2/3 complex also represses gene expression when it associates with ATF3 
[93], suggesting it has various roles in gene regulation. Recent ChIP-Seq studies also showed 
that SMAD1 binding overlapped with GATA1/2 in K562 cells, and could be re-directed to new 
binding sites with ectopic expression of CEBPα [94]. Ectopic expression of MyoD in mESCs 
also provided evidence that SMAD3 can be re-directed to new binding sites by this TF [95]. 
Collectively, these studies suggest that master TF regulators of cell fate can direct SMAD 
binding which putatively induces epigenetic remodeling and gene activation.    
  WNT/β catenin signaling has also been show to direct chromatin remodeling. WNT 
ligands bind to Frizzeled and LRP receptors on the cell surface, allows β catenin’s translocation 
to the nucleus where it interacts with TCF/LEF transcription factors to promote gene activation 
[96]. In addition to an overlap between GATA1/2 and SMAD1 previously mentioned, 	 ﾠ 11	 ﾠ
Trompouki and colleagues also found that TCF7L2 binding overlapped with SMAD1/GATA1/2 
binding, suggesting an overlap in WNT and BMP signaling pathways [94]. In some scenarios, 
the C terminus of β catenin directly interacts with the HMTs MLL1/MLL2 to stimulate H3K4 
methylation, which leads to expression of genes such as c-Myc [97].  Modulation of these 
pathways through extracellular binding of ligands therefore represents a mechanism that links 
developmental signaling cues with nuclear remodeling.  
   
1.7 Transcription Factors and the Epigenome   
  Unlike the pluripotent epigenome, somatic cells retain a restricted epigenetic landscape 
that does not readily respond to signaling cues in the same manner as embryonic stem cells. 
Nuclear remodeling can alternatively be induced by ectopic expression of TFs. With the report 
that ectopic expression of MyoD could induce a fibroblast to acquire myotube-like 
characteristics, many began to explore the ability of lineage specific TFs to engage with and 
remodel the epigenome in an ectopic context [98]. TF-mediated reprogramming experiments 
were complimented by studies using cell fusion and somatic cell nuclear transfer (SCNT), which 
demonstrated the ability to revert somatic nuclei to pluri- and totipotency, respectively [99]. 
However, arguably the most notable advancement in the understanding of TF capabilities came 
with the report of successful reprogramming of a somatic cell to an induced pluripotent state by 
ectopic expression of OCT4, SOX2, KLF4 and c-MYC (OSKM). This suggested that at some 
frequency, TFs could remodel the epigenetic state of a restricted cell type back to an open, 
pluripotent state.   
While the reprogramming process does result in the derivation of a seemingly pluripotent 
population, it exhibits limited efficiency suggesting that only a fraction of the somatic genome is 	 ﾠ 12	 ﾠ
amenable to epigenetic remodeling as a result of ectopic OSKM expression. To define the 
epigenetic landscape that determines susceptibility to OCT4 binding and directed remodeling in 
somatic cells, Taberlay and colleagues found that putative enhancer regions enriched for 
H3K27me3 permit OCT4 binding if a nucleosome-depleted region (NDR) is nearby [100]. The 
NDR is significant in this context, as it’s creation is a necessary step in the regulation of 
transcription and suggests that additional proteins have already bound to the site and created an 
accessible chromatin landscape [101].  
Ectopic expression of OCT4 in human fibroblasts confirmed that this TF could bind to 
the NDR within the H3K27me3-enriched enhancer of MYOD, subsequently leading to the 
remodeling of the promoter to a bivalent state. A complimentary report suggested that OCT4 
could promote establishment of NDRs at TSSs, exclusively in the absence of DNA methylation 
[102]. These results suggest that enrichment of H3K27me3 within distal regulatory elements 
provides a degree of local permissiveness to TF binding and chromatin remodeling. c-MYC, a 
non-essential reprogramming factor, is categorized as a transcriptional pause release factor, and 
also likely exhibits a limited ability to engage heterochromatin. It associates with the Pol II pre-
initiation complex, which cannot assemble without pre-existing H3K4 methylation [57, 103, 
104].  
In contrast to the restricted capacity of OCT4 and c-Myc, TFs such as FOXA1 exhibit a 
relatively unique ability to access and remodel target chromatin in an ATP-independent fashion 
in vitro [105-107]. A group of factors with this ability “pioneering transcription factors,” defined 
by their ability to remodel heterochromatic regions subsequently leading to open chromatin and 
transcriptional activation [108]. Consequently, many TF combinations that include pioneer 
factors have been successfully used to induce a somatic cell to assume a new, alternative identity 	 ﾠ 13	 ﾠ
[98]. Pioneering factors such as FOXA1 and GATA4 perform their chromatin remodeling 
functions as monomers [109-111], unlike OCT4, which requires dimerization with SOX2 for 
functionality in a pluripotent context [112, 113]. Further insight regarding the role of 
dimerization during reprogramming was provided by a recent demonstration that SOX17 could 
be transformed into a reprogramming factor by changing specific residues that promoted its 
interaction with OCT4 [114]. While the DNA binding profile of the amended dimer was not 
directly interrogated, the ability of multiple Sox family members to serve as iPSC 
reprogramming factors suggests that OCT4 may dictate DNA binding specificity while SOX2 
recruits HATs, such as p300 [115, 116]. The binding site preference for OCT4 is related to 
available co-factors, given that OCT4’s interaction with SOX17 during differentiation leads to 
regulation of different genes compared to the OCT4/SOX2 dimer that is active in ESCs [117]. 
Interestingly, Hiryai et al recently affixed the transactivation domain (TAD) of MyoD to 
OCT4, and examined this engineered factor’s ability to promote the reprogramming of MEFs 
[118]. Indeed they found that substituting the endogenous form of OCT4 with the TAD fusion 
construct accelerated the appearance of OCT4 positive colonies during reprogramming. This 
suggests that the endogenous form of OCT4, in combination with the other reprogramming 
factors (SKM), has limited inherent ability to access and remodel heterochromatic regions 
independently, and that this constraint can be relaxed by introduction of the TAD. Potentially 
contributing to this limitation is the stability with which these factors bind to DNA given 
evidence that forkhead domain-containing factors remain bound to mitotic chromosomes [119], 
while Pou family members do not [120, 121]. However this function, known as bookmarking, is 
associated with pioneering transcription factors [122]. The ability to interact with DNA and 
cause epigenetic remodeling is therefore variable between different classes of TFs.   	 ﾠ 14	 ﾠ
1.8 Specific Aims 
  At the inception of my thesis work, genome-wide profiles were available for various 
histone modifications, as well as transcription factors, derived from both pluripotent and somatic 
cell types. Basic associations, such as H3K4me3 enrichment at promoters and H3K4me1 at 
putative enhancers, were well established. Many cell type-specific regulatory elements and 
general genome-wide remodeling trends had also been reported. However, these observations 
were made by comparing profiles of unrelated cell types, such as pluripotent stem cells and 
immortalized cell lines, limiting our understanding of how a genomic region transitions to a new 
epigenetic landscape during development and differentiation.  
  Consequently, our goal was to create an in vitro system that would reveal transient 
epigenetic states associated with lineage decisions, similar to those that dictate embryonic 
development. We additionally hypothesized that the creation of this system would offer the 
opportunity to identify individual factors that induce these transitions, and assess whether these 
factors acted in a lineage specific manner. Therefore, we chose to use directed differentiation of 
hESCs to illuminate the epigenetic events that facilitate silencing of the pluripotent network and 
simultaneous activation of lineage specific programs.  
  By modulating the signaling environment that maintains pluripotency of human 
embryonic stem cells, we induced hESC differentiation to three distinct populations that 
resembled ectoderm, mesoderm and endoderm using 2-dimensional (2-D) directed differentiation 
(Chapter 2). We then performed RNA-Sequencing (RNA-Seq), ChIP-Seq for six histone 
modifications and WGBS on each population, as well as the starting hESCs (Chapter 2), to 
define transcriptional and epigenetic dynamics shared by all lineages, as well as those events that 
are lineage specific. Given that the gain of DNA methylation is associated with stable repression 	 ﾠ 15	 ﾠ
of gene regulatory elements, we first focused our analysis on DNA methylation dynamics to 
identify regulatory elements that are silenced during specification, and to understand the timing 
and consistency of these events across each germ layer (Chapter 3). This analysis was 
complimented by OC4, SOX2 and NANOG (O/S/N) binding profiles in hESCs, which we 
created to first define elements associated with the core pluripotency network and subsequently 
to understand the timing and mode involved in their transition to a stably repressed state. To 
understand the process by which lineage specific gene networks are activated, we then integrated 
the DNA methylation and ChIP-Seq data to identify regions that transition to a euchromatic state 
during differentiation (Chapter 4). We additionally created a binding profile for FOXA2 in the 
endoderm population to expand our understanding of its role during specification (Chapter 4). 
Collectively, this extensive data set uncovers epigenetic dynamics that accompany lineage 
specification in vitro.  
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2.1 Rationale 
  Cellular specification involves a complex series of molecular decisions that are based on 
interpretation of a myriad of signaling cues. While previous genetic studies have established that 
epigenetic remodeling is essential for specification, the precise genomic locations of epigenetic 
remodeling events that facilitate human embryonic lineage specification have not been widely 
identified. The first goal of my thesis was to derive populations that represent each embryonic 
germ layer through directed differentiation of hESCs, and then subject these populations to 
epigenomic profiling. We believed that this would allow us to identify regions of regulatory 
significance that are associated with specification, and reveal genome-wide trends associated 
with lineage decisions.  
 
2.2 Derivation of Three Populations that Resemble Embryonic Germ Layers 
  We chose to work with the male line, HUES64, which was expanded and maintained on 
murine embryonic feeders (MEFs) in the presence of knockout serum replacer (KSR) and basic 
fibroblast growth factor (bFGF, 10ng/mL). This line actively stained positive for pluripotent 
markers such as NANOG and OCT4 when cultured in feeder-free conditions (Figure 2.1, left), 
which we defined as matrigel coated plates and mTeSR medium. After allowing the cells to 
acclimate to this culture environment, we used one of three approaches to induce direct 
differentiation of distinct lineages. HUES64 readily differentiated into a neuroectoderm-like 
progenitor population positive for SOX2 and PAX6 by adding medium containing KSR and 
antagonists of TGFβ, WNT and BMP signaling (Figure 2.1, top right) [124]. We altered the 
previously published protocol due to reports that sustained WNT signaling can prevent neural 
differentiation [125]. Alternatively, canonical mesoderm markers, such as GATA2 (Figure 2.1, 	 ﾠ 18	 ﾠ
middle right) and HAND2, were induced by switching the culture environment to low serum 
(0.5%) and adding ACTIVIN A, BMP4, VEGF and FGF2 [126]. Differentiation towards a 
definitive endoderm-like fate, positive for markers such as SOX17 and FOXA2 (Figure 2.1, 
bottom right), was induced by again switching to a lower serum environment (0.5%) and adding 
ACTIVIN A and WNT3A [127, 128].   
 
 
Figure 2.1 Left: Low (4×) and high (40×) magnification overlaid immunofluorescent images of 
the undifferentiated hESC line HUES64 stained with OCT4 and NANOG antibodies. Right: 
Directed (two-dimensional) differentiation conditions were used to generate representative 
populations of the three embryonic germ layers. Cells were fixed and stained after 5 days of 
differentiation with the indicated antibodies. Representative overlaid images at low (10×) and 
high (40×) magnification are shown. DNA was stained with Hoechst 33342 in all images. Scale 
bars, 200 μm (4×), 100 μm (10×), and 30 μm (40×).   
   
  To understand the transcriptional dynamics within the first five days of differentiation, 
we measured the expression of 541 selected genes, including many developmental transcription 
factors and lineage markers, using NanoString profiling, at 24-hour intervals during 
differentiation towards each respective germ layer. NanoString is a semi-quantitative mRNA 
profiling method that measures mRNA molecules independent of PCR amplification [129]. 
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Figure 2.2 NanoString nCounter expression data (Z score log2 expression value of two 
biological replicates) for a time course of in vitro differentiation using the conditions shown in 
(2.1). 541 genes were profiled, and 268 genes that changed by more than 0.5 are displayed. 
Selected genes are shown on the left for each category that was identified based on hierarchical 
clustering. 
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  We found that 268 of these genes exhibited expression changes compared to hESCs 
during the first five days of differentiation (Figure 2.2). Mesendodermal genes, such as EOMES, 
T, FOXA2 and GSC, were upregulated at 24 hours of mesoderm and endoderm induction, but not 
ectoderm differentiation (Figure 2.2). GSC expression decreased within 48 hours of 
differentiation in the mesoderm-like population, while the expression level was maintained in the 
endoderm population (Figure 2.3A). EOMES and FOXA2 expression was also maintained in the 
endoderm population accompanied by upregulation of GATA6, SOX17 and HHEX (Figure 2.2). 
After transient upregulation of mesendodermal markers, activation of mesodermal markers such 
as GATA2, HAND2, SOX9 and TAL1 was detected specifically in the mesoderm conditions 
(Figure 2.2, 2.3B). By day 5, expression of genes such as PAX6, SOX10 and EN1 were detected 
in the ectoderm popuation (Figure 2.3C). Multidimensional scaling confirmed that at 24 hours, 
the mesoderm population is very similar to the endoderm, while the ectoderm population has 
already moved in an alternative direction (Appendix, Figure S1). 
  To confirm that these cells were in fact differentiated, we also examined expression of 
pluripotency related genes. We found that OCT4 and NANOG expression was maintained in our 
endoderm population (Figure 2.3D, E). This is consistent with prior studies indicating that 
OCT4 and NANOG expression is detected during the course of early endoderm differentiation 
and supports NANOG’s suggested role in endoderm specification [130]. SOX2 expression was 
downregulated in mesoderm and to a lesser degree in endoderm, but maintained at high levels in 
the ectoderm population (Figure 2.3F), while ZFP42 (REX1) was similarly down regulated in 
all three lineages. Based on these results, we selected day five as the optimal time point to 
capture early regulatory events in differentiated populations representing all three germ layers. 	 ﾠ 21	 ﾠ
	 ﾠ
Figure 2.3 A-F The average log2 expression values from two biological replicates of six genes is 
shown. Error bars represent 1 standard deviation (SD). If no error is evident, SD < 0.2 log2 
expression units. 
 
We confirmed that these populations indeed represented a precursor stage for each 
respective lineage by inducing them to differentiate further, which resulted in upregulation of 
genes such as OLIG2 and SST in the ectoderm [131], TRPV6 in the mesoderm [126], and AFP 
and HGF in the later endoderm populations [132] (Appendix, S2).  
To reduce heterogeneity, we used FACS to enrich for the desired populations based on 
previously reported surface markers (Appendix, S3). Populations isolated by FACS are herein 
referred to as dEC for the ectoderm, dME for the mesoderm and dEN for the endoderm. 
Expression analysis of the sorted populations confirmed enrichment for the desired populations 
(Figure 2.4). For example, profiling of the unsorted ectoderm population suggested that SOX17 
was expressed during ectoderm differentiation. Sorting of the day 5-ectoderm population 
revealed that while the CD56h/CD326l population maintained expression of PAX6, EN1 and 
SOX2, expression of SOX17 was reduced to background levels (Appendix, S4). 	 ﾠ 22	 ﾠ
Immunofluorescent staining confirmed that the SOX17 and PAX6 positive populations were 
mutually exclusive (Appendix, S4). We concluded that sorting was necessary to facilitate our 
downstream analysis.  
 
Figure 2.4 NanoString nCounter profiling of FACS-isolated ectoderm (dEC), mesoderm (dME), 
and endoderm (dEN). Expression levels for MYOD1 (right) are included as a negative control. 
The average log2 expression value of two biological replicates is shown. Error bars represent 1 
SD. If no error is evident, SD < 0.2 log2 expression units. 
 
2.3 Global Expression Analysis 
  We next expanded on our NanoString expression profiles by performing strand specific 
RNA-Seq on poly-A fractions from each of the FACS-isolated populations and undifferentiated 
HUES64 (see Methods). Hierarchical clustering using the Jensen-Shannon metric based on the 
global expression profiles of each cell type revealed that the dEN and dEC were more similar to 
each other than to dME or hESCs (Figure 2.5A). This was unexpected given that the dME and 
dEN populations are putatively derived through a common mesendoderm precursor stage based 
on NanoString profiling while the dEC did not upregulate similar markers (Figures 2.2). Overall, 
14,196 RefSeq-defined coding and non-coding transcripts were expressed (Figure 2.5B, 
Fragments per kilobase of transcript per million mapped reads (FPKM: >1) in at least one of the 
populations (≈38% of transcripts measured), 	 ﾠ 23	 ﾠ
 
Figure 2.5 (A) Hierarchical clustering of global gene expression profiles as measured by strand-
specific RNA-seq for biological replicates shown as a dendrogram. Pairwise distances between 
the replicates were measured using the Jensen-Shannon distance metric. (B) Venn diagram 
illustrating unique and overlapping genes with expression FPKM > 1.  
 
with 11,579 (81.6% of the total number of transcripts expressed within our cell types) being 
expressed in all four populations (Figure 2.5B). 
  Examination of the overlap of genes expressed in each population revealed that the dME 
population exhibited expression of the largest number of unique genes (n=448, Figure 2.5B), 
such as RUNX1 (FPKM: 3.4) and HAND2 (FPKM: 17.8). Genes unique to pairs of the 
differentiated cell types also revealed that dEC and dME had the least in common (n=37, Figure 
2.5B), while the dEC and dEN had the most number of transcripts in common (n=171, Figure 
2.5B), consistent with our clustering analysis. Genes such as PAX6 (dEC FPKM: 25.9, dEN 
FPKM: 5.6) and NKX6.1 (dEC FPKM: 2.3, dEN FPKM: 3.3), which are each required for both 
brain [133] and pancreas development [134], were expressed in both the dEC and dEN. 
Canonical markers of embryonic development, such as FOXA2 (FPKM: 12.7) in the dEN and 
EN1 (FPKM: 5.8) in the dEC were restricted to their expected germ layers in the populations that 
we profiled.  
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Figure 2.6 Differential splicing and downregulation of DNMT3B during directed differentiation 
to each cell type (FPKM). 
   
  Notably, we also identified 1,296 splicing and alternative promoter usage events within 
our populations (FDR=5%) [135]. For example, we detected expression of multiple isoforms of 
DNMT3B (p=5x10
-5). Expression of DNMT3B isoform 1 (NM_006892) was restricted to the 
undifferentiated hESCs (FPKM: 214.3), while the differentiated cell types predominantly 
expressed an alternative isoform, DNMT3B isoform 3 (NM_175849), though at much lower 
levels compared to hESCs (Figure 2.6). DNMT3B3 is expressed in various cancers and adult cell 
types, but our results suggest that this switch coincides with the exit from the pluripotent state, 
regardless of the specified lineage [136-138]. This splicing event also occurs during murine 
embryonic development [139] and it is particularly intriguing because this isoform does not 
maintain DNA methyltransferase activity [140]. 
  Extending our analysis to include non-coding elements, we identified 3,219 long non-
coding RNAs (lncRNA) that were longer than 200bp, spanned an intron and were expressed at 
>0.25 FPKM within our four populations. lncRNAs appear to be expressed at lower levels than 	 ﾠ 25	 ﾠ
protein coding genes, hence the lower expression threshold [141]. Unlike protein-coding genes, 
few of lncRNAs identified in our cell types include CpG islands in their promoter, which was 
confirmed by an additional report on hESC differentiation [142]. Though one divergent example 
is the non-coding element megamind, which includes a CpG island at its promoter. This 
transcript was originally identified in an analysis designed to uncover novel lncRNAs involved 
in zebrafish development [143]. The zebrafish transcript was expressed in the retina and brain at 
28 hours post-fertilization, and morpholino-facilitated depletion during development resulted in a 
smaller brain, and loss of NeuroD-positive neurons in the retina, among other phenotypes. 
Interestingly, this lncRNA is expressed in our dEC, suggesting conservation of this element in 
the human ectoderm lineage. The expression dynamics presented here suggest that we have 
isolated three distinct populations that represent different embryonic germ layers.       
	 ﾠ
2.4 Integrative Analysis of Epigenetic Dynamics  
  To gain a more complete picture of the underlying molecular dynamics that dictate 
specification of the three germ layers, we collected approximately 10 million cells of the 
respective dEC, dME and dEN populations, as well as HUES64, and subjected to them ChIP-Seq 
(data is publicly available through the NIH Roadmap Epigenomics Project data repositories: 
http://www.roadmapepigenomics.org/). We chose the modifications H3K4me1 and H3K4me3 to 
demarcate open enhancers as well as promoters, H3K36me3 for transcribed gene bodies, 
H3K27me3 and H3K9me3 to identify repressed regions and H3K27ac to identify active 
enhancers. Three genomic loci and their associated epigenetic landscape are depicted in Figure 
2.7.  	 ﾠ 26	 ﾠ
 
 
Figure 2.7 WGBS (% methylation), ChIP-Seq, and RNA-Seq for the undifferentiated hESC line 
HUES64 at three loci: NANOG (chr12: 7,935,038-7,957,818), GSC (chr14: 95,230,449-
95,250,241), and H19 (chr11: 2,015,282-2,027,359). CGIs are indicated in green. 
 
   
  After completing our basic quality control (see methods), we focused our analysis on 
previously identified informative chromatin states associated with various types of regulatory 
elements [42, 43], including the following specific combinations: H3K4me3+H3K27me3, 
H3K4me3+H3K27ac, H3K4me3, H3K27me3+H3K4me1, H3K4me1, H3K27ac+H3K4me1, 
H3K27me3 and H3K9me3. To identify genomic regions of enrichment for each histone 
modification, we segmented the genome in to non-overlapping windows and calculated 
enrichment based on the number of unique reads whose midpoint was located within the window 
of interest, compared to the enrichment within the corresponding window in the input control 
sample. Regions that exhibited >3 fold enrichment over background at a significance level of p 
<10
-5 were considered enriched [144]. Enriched windows occurring within 850bp of each other 
were merged together in to one region, whereas regions smaller than 400bp were excluded. Then, 
regions enriched for multiple histone modifications were identified. In addition, we segmented 
the genome-wide DNA methylation levels in to three CpG methylation states [11]: highly 	 ﾠ 27	 ﾠ
methylated regions (HMRs: >60%), intermediately methylated regions (IMRs: 11-60%) and 
unmethylated regions (UMRs: 0-10%). The latter differs from the generally high methylation 
level throughout the majority of the genome and likely indicates functional importance as 
previously suggested [11].  
  We next assigned each genomic region to one of the resulting states (Figure 2.8A). Of 
the identified epigenetic states, dynamic regions that were H3K9me3-enriched or HMRs covered 
the most base pairs (Figure 2.8B) and the combination of H3K4me3 and H3K27me3 exhibited 
the highest CpG content (Figure 2.8C), as expected given the close association between 
H3K27me3 and high CpG density [49]. Regions of open chromatin, enriched for H3K4me3 
exhibited the highest median expression value (Figure 2.8D). The size of dynamic regions 
spanned 400 bp to 10 kilo base (kb) (Figure 2.8E) and many dynamic regions were distal, as 
48.8% were located greater than >50 kb from the nearest TSS (Figure 2.8F). 
  Across the four cell populations, we identified 268,062 genomic regions that cover a total 
of 450,058,678 bp, that were enriched for at least one of the 8 chromatin states and/or classified 
as an IMR or UMR in at least one of the cell types. During differentiation, 157,443 regions 
changed their state in at least one of the populations (Figure 2.9). Interestingly, overall we found 
that ≈62% of all epigenetic state changes are not directly linked to transcriptional changes based 
on the expression of the nearest gene using RNA-Seq (change >1.5 fold).  
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Figure 2.8 (A). Definition of epigenetic states used in this study.  (B) The genomic space 
occupied by these states in the four cell types under study. (C) Median CpG content of the 
genomic regions in distinct epigenetic states. (D) Median expression level of epigenetic states 
used in this study based on assignment of each region to the nearest RefSeq gene. Median was 
computed over the states in all four-cell types and the corresponding expression profile. (E). Size 
distribution of genomic regions enriched for at least one of our six histone modifications in at 
least one cell type and/or classified as UMR or IMR in at least one cell type. (F) Genomic 
features associated with all regions that change their epigenetic state in at least one cell type. 
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 Figure 2.9 (A)	 ﾠEpigenetic state map of regions enriched for one of four histone modifications in 
at least one cell type or classified as UMR/IMR in at least one cell type and changing its 
epigenetic state upon differentiation in at least one cell type (n = 157,443). (B) Regions bound by 
OCT4, SOX2, and NANOG, as determined by ChIP-seq and organized using the chromatin 
states in A.  
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  We also mapped O/S/N in HUES64, to identify epigenetic states commonly associated 
with their binding. All three factors were found at regions of euchromatin (Figure 2.9B), in 
particular those enriched for H3K4me1 and H3K27ac. The remodeling associated with their 
binding will be discussed in greater detail in Chapter 3.  
  Because previous reports suggested genes essential for development are held in a bivalent 
chromatin state in hESCs, we specifically explored the resolution of these domains during 
differentiation. We identified 4,639 proximal bivalent domains in hESCs and observed  
   
 
Figure 2.10 (A) Chromatin state map for all TFs that are bivalent in hESCs and change their 
epigenetic state in at least one cell type (n = 400). (B) Normalized ChIP-seq tracks of H3K4me3 
and H3K27me3 at the ISL1 locus (chr5: 50,661,163-50,703,879) indicating H3K27me3 is 
selectively maintained at high levels in dEC and dEN but not dME, where H3K4me3 increases 
while H3K27me3 is lost, promoting active transcription. Read counts on y-axis are normalized to 
10 million reads and CGIs are indicated in green. 
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that 3,951 (85.1%) of these domains were no longer considered bivalent in at least one hESC-
derived cell type (Figure 2.9A). Examining these domains more closely revealed that 463 of 
these domains are located at the promoters of TF-encoding genes, and 400 of these genes change 
their chromatin state in at least one differentiated cell type (Figure 2.10A). In dME and dEN, 
many transition to H3K4me3-only or H3K27me3-only in a lineage-specific manner, as shown 
for ISL1 (Figure 2.10B). In dME, H3K4me3 is gained at the ISL1 locus while H3K27me3 is lost, 
leading to expression (FPKM: 14.3). The lineage specific dynamics in this region are interesting 
given that this gene has known roles in all three germ layers, although at later stages [145-147].  
    
2.5 Conclusions and Discussion 
  The work presented in this chapter represents the development of a platform to observe 
epigenomic remodeling that accompanies lineage specification of hESCs. We first used 
NanoString profiling to monitor gene expression throughout five days of differentiation. This 
analysis showed that within 24 hours of differentiation induction, both the mesoderm and 
endoderm populations activated genes symbolic of the mesendoderm transition, such as 
BRACHYURY. After five days of differentiation, the NanoString profiles suggested that 
expression programs associated with early developmental stages of each germ layer were 
established. Expanding on our initial NanoString analysis using genome-wide expression 
signatures derived from RNA-Seq data, we found that each germ layer, as well as hESCs, 
exhibited few genes that were uniquely expressed. This result was most surprising for the dEC 
and dEN, because dEC differentiation involves inhibition of TGFβ signaling that is essential for 
endoderm specification. As with all of our results, we cannot exclude the possibility that 
heterogeneity existed within our populations, leading to biases within our analysis. 	 ﾠ 32	 ﾠ
Using the expression level of the nearest transcript as a means to correlate epigenetic 
remodeling with expression, we also found that many remodeling events could not be linked to 
significant changes in gene expression. This result could be explained by our definition of 
association, which may not be sufficient because we did not consider long-range genomic 
interactions that are also associated with gene regulation [148, 149]. But given that most 
remodeling occurred at intergenic regions, the lack of significant changes in expression may 
have resulted because of differential enhancer usage. For example, an active gene may switch 
enhancer usage during differentiation, registering two remodeling events, though its expression 
may not significantly change. Two examples of this behavior were displayed at the OCT4 and 
NODAL loci, which employ stage-specific enhancers during development [84, 150]. NODAL in 
particular had four nearby regions exhibit lineage specific remodeling.  
The lack of correlation between epigenetic remodeling and changes in expression may 
have also resulted because of thresholds that we imposed, which could prevent identification of 
genes that remain expressed, but changed their expression level. If we look more closely at the 
expression level of genes expressed in multiple cell types, signatures associated with each 
population become more distinct. For example, PAX6 is expressed at a higher level in the dEC 
(FPKM: 23.3) than in the dEN (FPKM: 5.21). The dEC and dEN may appear to be the most 
similar of the cell types that we interrogated because such information was disregarded in Figure 
2.5B. Changes in gene expression and/or protein levels may change both the homo- and 
heterodimerization capabilities of proteins, which may in turn change a protein’s affinity for 
DNA [117, 151]. 
Our splicing analysis suggested that both transcript levels and isoform expression also 
contribute to cellular identity, in addition to gene expression level. Alternative splicing of the 	 ﾠ 33	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DNMT3B gene resulted in expression of the catalytically inactive isoform in each of the three 
germ layers, suggesting the translated protein may have assumed a new function in the 
differentiation process. This additionally suggests that a hallmark of pluripotency is expression 
of a DNMT3B gene that demonstrates de novo methylation activity.  
The epigenomic profiling of each population also revealed distinct genome-wide 
epigenetic profiles at day five. 157,443 (≈58% of those identified) regions changed their 
epigenetic state during differentiation to at least one cell type. Most events were greater than 
10kb from the nearest TSS, which correlated nicely with a recent report that found 
approximately 45% of DHS sites occurred at intergenic regions [152]. We also found that many 
bivalent domains are not retained during differentiation. 
  While induction of differentiation resulted in three unique epigenomic states at day 5, we 
specifically noticed an intriguing trend associated with H3K27ac enrichment. While regions that 
contained both H3K4me3 and H3K27ac exhibited the highest median expression level, not at all 
actively transcribed genes contained H3K27ac enrichment. In exploring this histone modification 
further, we found that H3K27ac enrichment occurred at genes that exhibit multiple transcription 
start sites, or genes that increased their level of expression in the differentiated cell types. For 
example, DNMT3B is down regulated during differentiation, exhibited an isoform expression 
switch and gained H3K27ac at the differentiation specific-TSS. Genes such as TPM2, HAND1 
and DKK1 did not exhibit changes in isoform expression but gained this modification, and 
experienced greater than 2-fold upregulation during differentiation. We hypothesize that 
H3K4me3 enrichment is required for pre-initiation complex assembly [153], but that H3K27ac 
enrichment leads to accessible chromatin recognized by factors that can reinterpret transcript 	 ﾠ 34	 ﾠ
information, potentially by inducing changes to Pol II pausing which was previously associated 
with alternative splicing [154].  
  In conclusion, we found that altering the signaling environment that maintains human 
pluripotency to mimic cues experienced during embryonic development causes genome-wide 
remodeling of the epigenetic landscape, with the majority of events occurring greater than 10kb 
from the nearest TSS. Our profiles identified many novel putative regulatory elements and the 
epigenetic mechanisms involved in their regulation, suggesting differentiation of hESCs is an 
excellent approach for studying human cellular transitions.     
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3.1 Rationale  
  While it is well established that DNA methylation is dynamic during differentiation and 
development, only recently have we begun to understand the discrete localization of specific 
regulatory elements that experience changes to DNA methylation. With the development of 
genome-scale sequencing assays, DNA methylation profiles of various populations were 
discerned. But many of these initial approaches included limitations that resulted in an 
incomplete appreciation of DNA methylation dynamics [155]. To overcome these limitations, 
the WGBS approach was developed. This assay provides the power to interrogate the 
methylation state of most cytosines within a genome in an unbiased manner, and has yielded 
important observations, such as the mutual exclusivity of transcription factor binding and high 
DNA methylation levels [10, 11]. We hypothesized that analysis of WGBS data collected from 
differentiated populations would reveal gene regulatory elements, and the associated genes, that 
are regulated by DNA methylation during lineage specification.  
     
3.2 DNA Methylation Dynamics During Differentiation 
  Our WGBS libraries for each differentiated cell type, as well as HUES64, covered 
approximately 26 Million CpGs (at ≥5 coverage) across all four cell types. First, we performed 
hierarchical clustering analysis of the WGBS data to understand the genome-wide similarities 
between the populations, and included human adult liver and hippocampus for comparison. This 
revealed that the pluripotent hESCs and the hESC-derived cell types form a separate cluster arm 
with respect to the somatic tissues (Figure 3.1).  
 






Figure 3.1 Hierarchical clustering of hESCs, hESC-derived populations (dEC, dME, and dEN), 
human adult hippocampus, and human adult liver based on mean DNA methylation levels of 1 
kb tiles across the human genome using Pearson Correlation Coefficient (PCC). 
 
 
Next, we aimed to identify regions that change their DNA methylation state during 
differentiation at a statistically significant level. We defined differentially methylated regions 
(DMRs) as 1 kb windows that exhibited a CpG methylation level difference ≥0.1 between hESCs 
and the differentiated population (p≤0.05), using CpGs covered by ≥ 5 reads. We observed that 
the dEN exhibited far more regions that gained DNA methylation (n=1,963) compared to dEC 
(n=546) and dME (n=707) (Figure 3.2A, top), with the majority of regions found greater than 
10kb in distance from the nearest TSS (Figure 3.2A, bottom). Most regions that increased their 
DNA methylation level were categorized as an IMR in hESCs, suggesting the switch from an 
unmethylated region to a highly methylated region was uncommon. Interestingly, only 65 of the 
total number of DMRs identified that gain DNA methylation were shared between all three 
populations (Figure 3.2B). However, reaffirming that our populations were depleted of 
pluripotent cells, this group of DMRs included the enhancer region of OCT4 (Appendix, Figure 
S5). In examining these regions further, we found that most regions exhibited enrichment of one 
or more histone modifications in hESCs (Figure 3.2C). Promoters that gained DNA methylation  	 ﾠ 38	 ﾠ
         
  
Figure 3.2 (A) Top: Regions that significantly (p ≤ 0.05) increase their DNA methylation levels 
by at least 0.1 between hESCs and the differentiated cell types. The color code indicates the 
DNA methylation state found in hESCs. Bottom: Genomic features associated with DMRs 
gaining DNA methylation in each of the differentiated cell types based on Ref Seq gene 
annotation and de novo discovered promoters by RNA-seq. (B) The overlap of differentially 
methylated regions (DMRs) that increase their DNA methylation level in the three hESC-derived 
populations. (C) Chromatin state in hESCs at regions that gain DNA methylation during 
differentiation. (D) Promoters (left) and distal elements (right) that gain DNA methylation 
separated by the changes in FPKM at associated genes. 
 
in dEC and dME were associated with a decrease in expression (Figure 3.2D), while 
transcriptional silencing was less frequently correlated with gain of DNA methylation at distal 
elements (Figure 3.2D). 
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Figure 3.3 (A) Regions that significantly (p ≤ 0.05) decrease their DNA methylation levels by at 
least 0.1 between hESCs and the differentiated cell types. The color code indicates the DNA 
methylation state distribution in the differentiated cell types. Genomic features (bottom) 
associated with DMRs losing DNA methylation in each of the differentiated cell types based on 
Ref Seq gene annotation and de novo discovered promoters by RNA-Seq. (B) Venn diagram of 
identified DMRs that decrease their DNA methylation level between the three hESC-derived 
populations. (C) Chromatin state in differentiated cell types at regions that lose DNA 
methylation during differentiation. (D) Promoters (left) and distal elements (right) that gain DNA 
methylation separated by the changes in FPKM at associated genes. 
 
   
Loss of DNA methylation was alternatively biased towards the dEC (n=2,313) (Figure 
3.3A), but similarly occurred at regions that were not proximal to a TSS (Figure 3.3A). This 
transition occurred in a more lineage specific fashion than gain of DNA methylation, with only 3 
regions shared by all three lineages (Figure 3.3B). More than 70% of DMRs that lose DNA 
methylation during differentiation were enriched for one of our profiled histone modifications in 
the differentiated populations, in particular H3K4me1 or H3K27ac (Figure 3.3C), marks 	 ﾠ 40	 ﾠ
commonly found at enhancers. On a global scale, an immediate correspondence between loss of 
DNA methylation and expression occurred at approximately half of the regions (Figure 3.3D).  
   Regions that lost DNA methylation in the dEC were associated with neuronal gene 
categories (for instance: neural tube development, q=3.13x10
-13). This includes the ectodermal 
TF POU3F1, which had a bivalent promoter in hESCs, resolved to a H3K4me3-only state and 
exhibited transcriptional activation in dEC. Chromatin remodeling and activation at this locus 
coincided with specific loss of DNA methylation at a putative regulatory element downstream of 
the 3’UTR of this gene in dEC (Figure 3.4). 
                 
Figure 3.4 DNA methylation at the POU3F1 locus (chr1: 38,493,152-38,532,618). The heat map 
below shows the DNA methylation values of individual CpGs within the gray region. The 
average DNA methylation value for the entire highlighted region is shown on the right in red. 
CGIs are shown as green bars. Expression values (FPKM) are displayed on the right. 
 
Examination of known regulators of signaling pathways involved specification revealed 
that the NODAL locus exhibits DNA methylation dynamics at multiple regions (Figure 3.5.). 	 ﾠ 41	 ﾠ
The expression level of this gene is similar in both hESCs and the dEN (FPKM: 11.6, 10.3) in 
our system, while it is repressed in the dEC and dME (FPKM: 0.04, 0.14). NODAL employs two 
distinct cis-regulatory enhancers that control lineage and cell type-specific expression of the gene 
during pre-implantation development. Genetic studies in mice showed that deletion of the 
intragenic enhancer (ASE) limited NODAL expression to the proximal epiblast, while it was 
absent from the visceral endoderm and left lateral plate mesoderm [156, 157]. An upstream 
enhancer was alternatively necessary for expression in the node, and sufficient for induction of 
mesoderm [156, 158].  
The ASE and the upstream enhancer gain DNA methylation in the dEC and dME, but not 
the dEN. The upstream enhancer is enriched for H3K4me1 in hESCs, and loses this mark while 
also gaining DNA methylation in the dEC and dME (Figure 3.5). Therefore, NODAL expression  
during definitive endoderm differentiation correlated with open chromatin at the ASE and 
upstream enhancer, suggesting these elements are also required during human post-implantation 
endoderm specification. We also identified an additional region further upstream that maintained 
H3K4me1 enrichment and low DNA methylation in hESCs, but it gained DNA methylation in 
all three hESC-derived populations. The gain of DNA methylation at the novel putative enhancer 
suggests that it is not required NODAL expression after specification of the germ layers. 
 
3.3 Epigenetic Remodeling at OCT4/SOX2/NANOG Binding Sites  
  We next examined the DNA methylation state in the differentiated populations at regions 
bound by O/S/N in hESCs, factors included in the core pluripotency network [159], to 
understand if the previously reported depletion of DNA methylation in hESCs was maintained 
during differentiation [10].      	 ﾠ 42	 ﾠ
 
Figure 3.5 WGBS and normalized H3K4me1 ChIP-Seq tracks for the NODAL locus (chr10: 
72,191,148-72,213,104). Enhancers are highlighted in boxes.  
 
NANOG exhibited the most unique binding sites (n=14,531), and SOX2 and OCT4 co-binding 
was the least frequent combination (n=956) (Figure 3.6A). 6% of identified sites were bound by 
all three factors, which was far less than previously reported [159]. Genome-wide, regions bound 
by all three factors (n=1,556), SOX2-only (n=923) or NANOG-only were frequently associated 
with intergenic regions rather than promoters (Figure 3.6B).  
Epigenetic remodeling at regions of O/S/N binding were of particular interest given that these 
factors are reportedly involved in differentiation [130, 160], therefore we were curious as to fate 
of their binding sites. Our analysis revealed a lineage specific trend towards a heterochromatic 
HMR state (Figure 3.7). Examination of regions in hESCs bound by OCT4, NANOG and SOX2 
individually showed H3K4me1 regions enriched for OCT4 binding sites frequently became 
HMRs in all three differentiated cell types, whereas NANOG and SOX2 sites were more prone 
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Figure 3.6 (A) Venn diagram of the overlap between OCT4, NANOG and SOX2 binding sites 
identified in hESCs (total overlap = 1,556). (B) Genomic features of OCT4/NANOG/SOX2 
binding sites.  
 
 
to switch to an HMR state in dME (Figure 3.7). In general, many regions associated with open 
chromatin that were bound by NANOG, were more likely to retain this state in dEN compared to 
dME and dEC (Figure 3.7). We also found that regions enriched for H3K27ac in hESCs that 
maintain this enrichment in dEN or dEC, were likely to be bound by SOX2 and NANOG. This is 
in agreement with the reported role of SOX2 during ectoderm development and differentiation 
[161], but also supports our observation that SOX2 expression is maintained in the dEN. We 
additionally found a slight enrichment for NANOG binding at bivalent domains that transition to 
H3K4me3 only in the dEN. Furthermore, we found that regions bound by OCT4, NANOG and 
SOX2 that gained an active mark in dEC were enriched for the PAX9 motif, a gene associated 
with later stages of neural crest development [162]. Inspection of DMRs associated with O/S/N 
binding sites revealed that many genes bound by these factors were associated with later stages 
of development rather than pluripotency, and they exhibited lineage specific remodeling 
dynamics. For example, two regions 20 kb downstream of DBX1, a gene associated 
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Figure 3.7 Enrichment of OCT4, SOX2, and NANOG within various classes of dynamic 
genomic regions changing upon differentiation of hESC, computed relative to all regions 
exhibiting the particular epigenetic state change in other cell types. Epigenetic dynamics are 
categorized into three major classes: repression (loss of H3K4me3 or H3K4me1 and acquisition 
of H3K27me3 or DNA methylation), maintenance of open chromatin marks (H3K4me3, 
H3K4me1, and H3K27ac), and activation of previously repressed states. 
 
with neural specification, were bound by all three TFs in hESCs and they gained DNA 
methylation in dME and dEN (Figure 3.8). However, they maintained low levels of DNA 
methylation in the dEC, the same population where active transcription was also detected 
(Figure 3.8). This may also explain why distal regions that gained DNA methylation did not 
exhibit a decrease in expression, as many regions may have been held in an open state for 
activation at a later time.  
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Figure 3.8 DNA methylation levels and OCT4, SOX2, and NANOG ChIP-seq at 
the DBX1 locus (chr11: 20,169,548-20,277,940).  
 
3.4 Conclusions and Discussion 
Taken together, this chapter prevents evidence that DNA methylation is quite dynamic 
during differentiation and exhibits an intriguing lineage bias. In contrast to a previous study, we 
found that changes in DNA methylation status are not commonly correlated with altered gene 
expression [11]. The dEN displayed the most regions that gain DNA methylation, and they were 
more commonly shared between differentiated cell types (n= 520, 20% of DMRs). This is likely 
because gain of DNA methylation represents lineage specific silencing of regulatory regions 
associated with pluripotency, an essential task each lineage must perform. We also found 	 ﾠ 46	 ﾠ
significant enrichment of various TF motifs associated with alternative lineages that are DNA 
methylation targets upon differentiation, which has some analogy to the gain of methylation 
observed at myeloid targets in the lymphoid lineage in vivo [16]. It is thought that regulatory 
elements required for all lineages are maintained in a euchromatic environment in the pluripotent 
state to promote ease of activation downstream, therefore once a lineage is a specified, these 
elements can be stably silenced by DNA methylation as they likely will not be required later in 
development.  
The bias towards gain of DNA methylation in the endoderm may result because 
NODAL/TGFβ signaling plays a prominent role in both promoting human pluripotency and 
directing endoderm specification, but they may employ different enhancer elements. Similar to 
the mechanisms of OCT4 [150] and NODAL regulation [156], DNA methylation may distinguish 
distal regulatory elements available for regulatory purposes for each state. The gain of DNA 
methylation may reflect a lineage choice that requires only a specific branch of TGFβ signaling. 
This concept of gradual restriction is a central theme in embryonic development.       
The asymmetric loss of DNA methylation was the most prevalent in the dEC and was 
highly lineage specific, with only 3 regions losing DNA methylation in all three lineages. 
Though each lineage exhibited gain of the enhancer-related histone modifications H3K4me1 and 
H3K27ac. In cooperation with our distance-to-TSS analysis for regions that loose DNA 
methylation, this supports recent evidence that enhancer elements remodel prior to promoters of 
associated genes [100]. We hypothesize that these events represent the initial stages of activation 
of enhancer regulatory elements required for ectodermal-differentiation that are not held in a 
euchromatic state in hESCs. 	 ﾠ 47	 ﾠ
Examining epigenetic dynamics at sites of O/S/N binding reveals that regions bound by 
one of these factors also showed a lineage specific preference for maintaining open chromatin in 
the differentiated cell types. Many regions bound by these factors were also not expressed in 
hESCs, but were associated with genes required at later stages of development, such as DBX1. 
Two discrete regions associated with this gene gained DNA methylation in the dME and the dEN, 
but not the population in which it was activated (dEC). This data suggests that O/S/N may serve 
an additional purpose by maintaining an open chromatin environment that allows exploitation of 
the regulatory element at a later time point. Additional support for their role in chromatin 
structure was presented by a report that found these factors are commonly bound with mediator, 
a protein essential for maintaining chromatin structure and interchromosomal looping [163]. This 
report was recently expanded on by the identification of “super-enhancers,” which found that 
multiple master regulators of cell fate, including Oct4 and Mediator, are commonly bound in 
close proximity to one another. These regions of concentrated binding were essential for 
maintaining the pluripotent state in vitro, but the dependency on the individual factors for proper 
chromatin architecture is unresolved.   
While studies relating Mediator to O/S/N binding associate these factors with chromatin 
structure, their ability to induce remodeling of chromatin versus maintaining previously 
established states is currently somewhat controversial. In an attempt to understand the chromatin 
binding affinity and remodeling capabilities of the reprogramming factors OSKM, one group 
mapped the binding sites of these proteins in adult fibroblasts at 48 hours –post OSKM induction. 
They found that most binding sites were distal to the TSS and they frequently overlapped regions 
resistant to DNaseI, a sign of closed chromatin, or H3K9me3. This led to their conclusion that 
OSKM can act as pioneers at genomic regions of closed chromatin. This conclusion may have 	 ﾠ 48	 ﾠ
been premature, as less than 50% of regions exhibiting 5hmC in hESCs overlapped with DHS 
sites [164]. Therefore, it is unclear what degree of heterochromatin is exhibited at OSKM bound 
sites that are resistant to DNaseI. Given that proteins exhibit distinct binding affinities depending 
on the methylcytosine state [165], we suggest that OSKM should not be considered traditional 
pioneer factors using their data set. However, an independent study identified 19 proteins present 
in mESC nuclear extracts that preferentially bound 5mC rather than unmethylated cytosine, 
including Klf4 [165].  
The mechanism by which OCT4, or any TF, is eliminated from its binding sites during 
differentiation and development to allow or promote repression is also unresolved. Eviction of 
OCT4 from its binding sites may be induced directly by gain of DNA methylation. Alternatively, 
POU factors do not remain bound to mitotic chromosomes, therefore addition of DNA 
methylation may prevent OCT4 from interacting with its binding sites after cell division is 
complete [120]. If this scenario were true, it suggests that additional factors maintain NDRs at 
OCT4 binding sites during cell division. While the evidence was limited, one report suggested an 
analogous mechanism for FoxD3 in maintaining a DNA methylation-free CpG upstream of the 
Alb gene, which promoted its efficient activation at a later stage of differentiation [166]. This 
phenomenon, also known as bookmarking, has been suggested for TFs such as GATA1 and 
FOXA1, which remain bound to mitotic chromosomes [122, 166]. While these two factors are 
not expressed in hESCs, many similar proteins such as the aforementioned FOXD3, as well as 
FOXB1 and FOXI3, are actively expressed in hESCs.       
  In conclusion, this chapter includes evidence that DNA methylation is quite dynamic 
intergenic regions bound by TFs during lineage specification, though changes are discrete and 
localized. We confirmed that regulatory elements associated with pluripotency gained DNA 	 ﾠ 49	 ﾠ
methylation in each lineage, suggesting they were stably repressed. A lineage bias was also 
detected within the DNA methylation analysis that may have interesting implications for 
understanding the regulatory networks employed by each lineage, as well as hESCs. Our O/S/N 
binding data also suggests that these TFs may be involved in maintaining an open chromatin 
state at regulatory elements that are required during later stages of development, rather than just 
in the pluripotent state. 	 ﾠ






Chapter 4.  








The work presented in this chapter is previously published. [123] 
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4.1 Rationale 
  While many reports have studied the dynamics that lead to silencing the pluripotent 
network, few studies have elaborated on the activation of lineage specific programs. The events 
that cause loss of high DNA methylation levels at genes required during later stages of 
specification, creating an environment amenable to transcriptional activation, is not well 
understood. These events are essential to the specification process as many genes associated with 
somatic cell types exhibit high DNA methylation at their regulatory elements in ESCs [14, 167].   
 
4.2 Acquisition of H3K4me1 at hESC-HMRs  
  To identify genes that transitioned to a euchromatic state during differentiation, we 
examined the epigenetic states of genes associated with downstream stages of development and 
differentiation. We found many regions that exhibit high DNA methylation in hESCs, and 
transition to H3K4me1 in one lineage, but remain highly methylated in the two alternative cell 
types (Figures 2.10A and 4.1A), analogous to remodeling events reported during 
reprogramming and cardiac differentiation [168, 169]. This remodeling trend occurred in all 
three lineages, providing evidence that this is a common transitory occurrence. Similar to the 
regions showing dynamic DNA methylation during differentiation, these regions were typically 
intergenic (Figure 4.1B).  
  To understand if regions that gain H3K4me1 are associated with somatic identity, we 
took advantage of published microarray data for 24 human tissues and determined genes 
upregulated in these tissues with respect to hESCs. Reaffirming the relevance of our dynamics, 
we found regions that gain H3K4me1 in dEC were associated with fetal brain, cortex and 
cerebellum (Figure 4.1C) based on region association with the nearest gene. The dME 	 ﾠ 52	 ﾠ
H3K4me1 pattern was associated with the heart, as well as unexpected tissues, which may be 
due to heterogeneity of the tissues collected. The dEN was associated with lung and pancreas, as 
well as fetal brain and cortex (Figure 4.1C).  
 
 
Figure 4.1 (A) Overlap of regions gaining H3K4me1 in the three differentiated populations 
relative to hESCs. (B) Genomic distribution of all regions gaining H3K4me1 compared to hESCs 
in at least one of the three differentiated populations. (C) Tissue signature enrichment levels of 
genes assigned to regions specifically gaining H3K4me1 in the differentiated populations 
indicated on the bottom.  
 
  To investigate these regions in more detail, we carried out motif enrichment analysis and 
found lineage specific enrichment of TF motifs near regions that gain H3K4me1. While the 
FOXA2 motif was enriched in all three cell types, the DBX1 motif was associated with the gain 
of H3K4me1 in dEC (Appendix, Figure S7), which coincided with its transcriptional activation 
in that cell type (FPKM: 5.36). Conversely, the GLI3, HIC1 and CTF1 motifs were strongly 
enriched at regions that gain H3K4me1 in dEN (Appendix, Figure S6). Overall, less than half of 
the genes that gain H3K4me1 exhibited immediate transcriptional changes (Figure 4.2A). 
CYP2A6 and CYP2A7 (Figure 4.2B) are representative examples that did not show a 
corresponding change in expression, while LMO2 was activated in the dME (Figure 4.2C). 	 ﾠ 53	 ﾠ
 
Figure 4.2 (A) Number and distribution of gene expression changes of genes assigned to regions 
gaining H3K4me1 in the differentiated populations. Associated genes were classified as either 
being up/downregulated or unchanged relative to hESCs. (B) Normalized ChIP-seq tracks 
(H3K4me1 and H3K36me3) for the LMO2 locus (Chr.11: 33,865,134-33,977,858). Read counts 
on y-axis are normalized to 10 million reads for each cell type. CGIs are indicated in green. (C) 
Normalized ChIP-seq tracks (H3K4me1 and H3K36me3) for the CYP2A6/CYP2A7 region 
(Chr19: 41,347,260-41,395,599). Read counts on y-axis are normalized to 10 million reads for 
each cell type. CGIs are indicated in green.  
 
 
To further assess if this DNA methylation-to-H3K4me1 switch acts as an epigenetic 
priming event, we differentiated the HUES64 endoderm population for five additional days in 
the presence of BMP4 and FGF2, leading to a hepatoblast-like (dHep) state and then performed 
RNA-Seq [132]. Interestingly, motifs enriched in dEN that gained H3K4me1, including HIC1 
(FPKM 1.46) and CTF1 (FPKM 5.32), became expressed at the next stage of differentiation, 
along with markers of the corresponding stage of hepatocyte differentiation, such as AFP 
(FPKM: 5.16) (Figure 4.3), and HHEX (FPKM: 3.32). 
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Figure 4.3 Gene expression levels of genes being upregulated between dEN and dHep (but not 














Figure 4.4 (A) Epigenetic state distribution in hESC, dEC, and dME of regions that gain 
H3K27me3 in the dEN population compared to hESC. (B) CpG content distribution of regions 
gaining H3K27me3 upon differentiation. For reference, the CpG content distribution of CpG 
islands is shown. (C) Distribution of genomic features associated with regions gaining 
H3K27me3 (n = 22,643).  
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4.3 FOXA2 Binding is Associated with Epigenetic Priming 
  We also observed that many intergenic regions switched from high DNA methylation to 
H3K27me3 in a lineage specific manner (n=3,985 in dEN) (Figure 4.4A) while maintaining the 
HMR state in the alternative cell types. This transition frequently occurred within CpG poor  
intergenic regions (Figure 4.4 B-C), which is distinct from the common CpG island-centric 
targets of PRC2. 
In an effort to identify factors that may be directing this remodeling, we utilized TF 
binding data from the ENCODE project [170]. By overlaying our epigenetic profiles with their 
TF binding data, we found many regions that exhibited the transition from HMR to H3K27me3 
enrichment in CpG poor regions in the dEN were near FOXA2 binding sites identified in the 
HepG2 cell line. FOXA2 is essential for endoderm development [171, 172], and in vitro studies 
showed that it binds more stably to nucleosomes rather than free DNA [173], which leads to 
chromatin decompaction in vitro [107]. Although, due to technical limitations associated with the 
in vitro assays employed in the aforementioned studies, FOXA2’s distinct chromatin 
remodeling-related functions and limitations remain somewhat unclear.                      
                                         
Figure 4.5 Composite plot of median normalized tag counts (reads per million RPKM) of 
regions bound by FOXA2 in dEN and gaining H3K27me3 in dEN compared to hESC (n = 357). 	 ﾠ 56	 ﾠ
We therefore hypothesized that this “pioneering” TF may induce this epigenetic 
transition from high DNA methylation to H3K27me3 enrichment. To investigate this association, 
we performed ChIP-Seq for FOXA2 in the endoderm population. As shown by the composite 
plot, this analysis revealed that FOXA2 binding sites frequently overlapped with regions that 
transition from a HMR state to a H3K27me3-containing state (Figure 4.5). In addition, this gain 
of H3K27me3 at FOXA2 binding sites predominantly occurred in dEN (Figure 4.5). A notable 
example of this transition was seen at the albumin locus, where H3K27me3 was gained at AFP 
and AFM, proximal to FOXA2 binding sites (Figure 4.6). This mark was not found at this locus 




Figure 4.6 Normalized H3K27me3 and H3K4me3 ChIP-seq tracks for hESCs, dEN, and human 
adult liver tissue at the ALB locus (chr4: 74,257,882-74,377,753).  
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Many regions that exhibit this transition are required for later stages of development as with AFP, 
or the hemoglobin locus in the dME 
Because H3K27me3 was gained at hESC-HMRS, next we compared DNA methylation at 
FOXA2 binding sites in hESCs to dEN, and found a slight reduction in the dEN (Figure 4.7). To 
more directly assess this relationship, we then interrogated the DNA methylation state of regions 
isolated by FOXA2-ChIP in the endoderm, also known as ChIP-bisulfite-sequencing (ChIP-BS-
Seq) [174]. This direct assay revealed a major depletion of DNA methylation at sites isolated by 
FOXA2-ChIP (Figure 4.7). The methylation value appeared only slightly depleted in the WGBS 
data because we computed the methylation value using each CpG under the FOXA2 peak, which 
included far more CpGs than those covered by ChIP-BS-Seq.  
                                              
 Figure 4.7 Distribution of methylation levels of regions bound by FOXA2 and gaining 
H3K27me3 in dEN. DNA methylation information is depicted for hESC and dEN WGBS data 
sets and two biological replicates of FOXA2 ChIP-bisulfite experiments in dEN (n = 357). 
 
  To determine if these regions exhibited transcriptional activation after further 
differentiation, we again examined our dHep RNA-Seq data. We found that 50 genes were bound 
by FOXA2, gained H3K27me3 in dEN and increased their expression in the dHep population 	 ﾠ 58	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(Figure 4.8), including AFP. Analysis of H3K27ac ChIP from human liver also revealed 
enrichment of 197 loci that had experienced gain of H3K27me3 in dEN, suggesting that these 
loci eventually transitioned to an active state (Appendix, Figure S7). We believe that de novo 
gain of both H3K27me3, as well as H3K4me1, serve as priming events that create an epigenetic 
state amenable to binding of additional factors that are not capable of inducing epigenetic 
remodeling, leading to gene activation at later stages of differentiation [100].   
                                                                
Figure 4.8 Gene expression profile of genes upregulated at the hepatoblast stage relative to dEN 
that are associated with regions bound by FOXA2 and gaining H3K27me3 in dEN (n = 50) 
 
 
4.4 Conclusions and Discussion  
The evidence summarized in this chapter suggests that the transition from high DNA 
methylation to a euchromatic state exhibiting enrichment of histone modifications frequently 
involves a transient state that we believe is a novel “primed” epigenetic state. We frequently 
detected HMRs that gained enrichment of H3K4me1 or H3K27me3, but they were not 
necessarily associated with transcriptional activation. We confirmed that a subset of related 
genes discovered in the dEN experienced activation during differentiation to the next stage 
towards hepatocytes. Recent studies have reported dynamics that suggest similar epigenetic 	 ﾠ 59	 ﾠ
priming events occur during cardiac differentiation [168]. These results are also reminiscent of 
changes that occur during the early stages of reprogramming towards the induced pluripotent 
state and highlight possible similarities between differentiation and de-differentiation. By 
isolating populations based on the number cell divisions post-OSKM induction, our lab 
previously reported that initial gene expression dynamics were predominantly observed at loci 
containing a preexisting euchromatic state as defined by H3K4 methylation and/or K3K27 
methylation [175]. In that study, a de novo or enhanced gain of H3K4me2 was observed at 
promoters of many pluripotency-associated genes prior to detectable transcription originating 
from these loci.  
In an effort to identify individual transcription factors that are associated with these 
priming dynamics, we examined previously published TF binding data and observed that pioneer 
transcription factor binding was associated with regions that gain H3K27me3 during hESC-
differentiation. FOXA2 binding profiles generated from the endoderm population confirmed its 
correlation with this epigenetic remodeling event. We additionally confirmed by ChIP-BS-Seq 
that these regions exhibited loss of DNA methylation during differentiation.  
Further analysis of the ChIP-BS-Seq was confounded by additional factors. DNA 
fragment sizes ranged from 300-600bps within our sequencing library, but TF motifs/binding 
sites range in size from 8-20bp. Consequently, we cannot distinguish between the two following 
scenarios; FOXA2 directly binds to methylated cytosines, or FOXA2 binds in the proximity of 
methylated cytosines. In the dEN, loss of DNA methylation was confined to FOXA2 peaks, but 
these peaks were greater than 400bp. Therefore, while we cannot conclude if FOXA2 binds 
methylated DNA directly, it appears that FOXA2 does not exert remodeling capabilities that 
spread throughout genomic regions. While it has previously been suggested that FOXA1, a 	 ﾠ 60	 ﾠ
paralog of FOXA2, has the ability to bind methylated regions and induce local remodeling, this 
function appears to be limited to a subset of TFs [1, 165]. Among many other interesting 
observations, Stadler et al also showed that similar to our observations regarding FOXA2, CTCF 
binding appeared to induce local demethylation, within 500bp of the binding site. Extracting 
more discrete information from this data was further complicated by the fact that FOXA2 bound 
regions were not CpG dense, and therefore encoded approximately 1 CpG/100bp. We only 
collected 50bp of sequence, severely limiting the number of reads that contained multiple CpGs. 
Addition of 5hmC enrichment may dramatically enhance our ability to address these lingering 
questions [164].  
It is also unclear whether binding recruits additional factors necessary for remodeling, or 
whether FOXA2 induces remodeling independently by inhibiting/stimulating epigenetic 
modifiers that it naturally interacts with while it’s bound to DNA. In vitro studies showed that 
FOXA factors could induce opening of chromatin independent of ATP, suggesting pioneer factor 
binding itself may be sufficient to initiate opening, though the DNA template did not include 
methylcytosine. FOXA2 peaks additionally appeared quite broad in the composite plot, though 
closer investigation revealed that multiple individual peaks were often identified close together 
(within 1kb), including at regions that gained H3K27me3. An in vitro system, which utilized the 
ALB enhancer sequence, found that FOXA2 binding directly altered nucleosome placement 
[176] can decompact a chromatin array in vitro [177]. With multiple binding sites close together, 
nucleosome placement and decompaction is potentially more finely controlled. Enrichment of 
H3K27me3 during NPC differentiation was also elevated when multiple SNAIL binding sites 
occurred in close proximity [83].  	 ﾠ 61	 ﾠ
Given that FOXA2 binding did not result in transcriptional activation of many loci in the 
endoderm population, this provides additional evidence that FOXA2 binding may be the first 
step in a cascade of events, which paves the way for additional factors to bind and promote 
transcriptional activation at later stages. Future studies should be directed at understanding the 
sequence of events, and establishing that these events are necessary for the timely activation of 
gene expression during specification.      
In conclusion, this chapter provides evidence that the process of activating regions 
required for differentiation involves the loss of DNA methylation and/or gain of histone 
modifications, such as H3K4me1 and H3K27me3. By defining discrete regions that undergo 
these transitions, we have also putatively defined factors that direct these events. These 
epigenetic transitions are not always coupled to significant changes in expression, which we 
hypothesize represents epigenetic priming that will allow activation of these loci at later stages of 













Chapter 5.  
Discussion and Future Studies. 	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 ﾠ
5.1 Summary 
Dynamic epigenetic regulation has been observed during the acquisition of new cellular 
identities, such as during embryonic development. While basic associations with transcriptional 
activity have previously been ascribed to epigenetic mechanisms, the precise regulatory elements 
that DNA methylation and histone modifications control to facilitate differentiation have not 
been widely studied in a human context for technical and ethical reasons. Thus, we chose to use 
2-dimensional directed differentiation of HUES64, a male hESC line, towards each major 
embryonic lineage to capture epigenetic remodeling that accompanies in vitro specification 
(Figure 2.1). During differentiation, each population exhibited transcriptional dynamics similar 
to those previously observed in vivo, such as the induction of BRACHYURY during mesoderm 
and endoderm differentiation (Figure 2.2). We employed FACS-based isolation to increase the 
homogeneity of the day five populations, and subsequent expression profiling revealed that each 
population resembled one of the three embryonic germ layers (Figure 2.4). Herein we will refer 
to FACS sorted populations as dEC (ectoderm), dME (mesoderm) and dEN (endoderm). 
Surprisingly, the global transcriptional landscape defined by RNA-Seq was quite similar between 
the three differentiated cell types and the hESCs (Figure 2.5), though notable differences 
between absolute expression levels and splicing were observed (Figure 2.6).  
Next, we performed ChIP-Seq for six histone modifications (H3K4me1, H3K4me3, 
H3K27me3, H3K27ac, H3K36me3 and H3K9me3) and WGBS to determine DNA methylation 
levels, on the three derived populations as well as HUES64. Integration of these data sets 
revealed that each population displays a distinct epigenomic state, categorized by widespread 
remodeling of both histone modifications and changes to DNA methylation levels compared to 
the undifferentiated HUES64 (Figure 2.9). We found expected commonalities between lineages, 	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such as the stable repression of regulatory elements associated with the pluripotent network 
(Figure S6) and alternative lineages (Figure 3.8). Alternatively, we also saw that enrichment of 
euchromatic histone modifications at O/S/N binding sites was sometimes retained in the 
differentiated cell types, suggesting a subset of regions bound by O/S/N may be involved in later 
stages of differentiation (Figures 3.7 and 3.8). We also uncovered regions of facultative 
heterochromatin that exhibit lineage specific loss of DNA methylation and/or gain of histone 
modifications such as H3K4me1 or H3K27me3 during differentiation (Figures 2.9, 4.1 and 4.4). 
This transition was pronounced at genes that did not concurrently exhibit transcriptional 
activation but are associated with later stages of differentiation in their respective lineages 
(Figures 4.3 and 4.8). We therefore termed these regions “primed,” to distinguish them from the 
common pool of repressed genes. While we cannot confirm that these events occur during 
embryonic development because we did not probe primary tissue, similar observations have been 
made in vivo [168].  
We also observed general trends throughout our analysis, such frequent epigenetic 
remodeling events that we cannot associate with significant changes in transcription. This is 
potentially explained by the observation that most events are intergenic, occurring greater than 
10kb from the nearest TSS, suggesting the majority of remodeling occurs at enhancer elements. 
A major lineage bias was also observed in the WGBS data, in that the dEC gained DNA 
methylation at many more regions than the dME and dEN, while the dEN had the most regions 
that lost appreciable amounts of DNA methylation. Using epigenetic dynamics as a proxy for 
regulatory significance, our data represents an expansive resource for identifying novel 
regulators of human embryonic specification.  
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5.2 Transcriptional Signatures Reveal Few Differences  
Based on RNA-Seq, our three differentiated cell types, as well as the hESCs, are quite 
similar on a gene expression level (Figure 2.5). For our analysis, we used annotations composed 
of mostly protein-coding elements with limited non-coding RNAs, suggesting that our 
similarities are due to protein-coding genes, which may be expressed ubiquitously throughout 
development. This is similar to a claim made by the ENCODE consortium where RNA 
sequencing of 14 cell lines that represented various lineages suggested that 53% of protein-
coding genes were detected in all cell lines, while only 7% were unique to one cell type [178].  
The sensitivity of the techniques that we used to measure expression afforded us the 
ability to make many interesting observations regarding expression. NanoString and RNA-seq 
generated quantitative, digital expression values that did not rely on comparison to a starting cell 
type for normalization. The limiting nature of alternative approaches, such as PCR and 
microarrays, may explain why SOX2 is not widely associated with definitive endoderm 
differentiation. This gene is downregulated during mesoderm and endoderm differentiation in 
our system, but quantitative approaches employed here allowed the observation that transcripts 
are still present in the dEN, suggesting the gene is not yet repressed. Growing evidence suggests 
that SOX2 is essential for endoderm development [179] and organ function [180].  
The NanoString and RNA-Seq analyses also reveal that to define the current lineage and 
developmental stage of a cell type using gene expression, many aspects should be considered. In 
addition to considering expression of multiple genes, isoform expression adds a beneficial layer 
of complexity to an expression analysis. Recent reports claimed that multiple isoforms could be 
expressed within one cell type [181], while > 90% of human genes reportedly undergo detectable 
alternative splicing [182]. We found >1,200 isoform switching events within our populations, 	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which includes alternative splicing and differential promoter usage. Some events, such as that 
seen at DNMT3B (Figure 2.6), suggest alternative functions for the encoded proteins given that 
the isoform expressed in the differentiated populations is not catalytically active [140]. We also 
identified expression of three PITX2 isoforms, with differential splicing occurring between the 
dME and dEN. PITX2 is essential for heart looping during chick development, but the isoform 
expressed in the dEN does not induce the same morphologic consequence [183].  
A major caveat to our analysis is that populations of cells are considered; we cannot 
conclude that every cell within the population expresses all transcripts detected using RNA-Seq. 
It is possible that multiple subpopulations exist, giving rise to one averaged transcriptional 
signature. Our analysis could be improved by performing single cell sequencing with 
considerations for small RNAs (such as enhancer RNAs or micro RNAs), non-polyadenylated 
transcripts and sub-cellular transcript localization transcript [184, 185]. Advances in single cell 
sequencing technology will provide even greater depth to our understanding of transcription in 
the near future. As technology improves, heterogeneity issues within population-based studies 
may become more apparent, forcing a new perspective on molecular regulation of cellular 
identity. These observations suggest that expression characteristics of combinations genes are 
crucial factors to consider when examining the transcriptional profile of a population. 
             
5.3 Ectoderm and Endoderm Lineages Exhibit Genome-wide Similarities 
Clustering analysis of the WGBS data revealed that the dME and dEN were more similar 
to each other than to the dEC (Figure 3.1). However, our transcriptional and histone 
modification analyses revealed that the dEC and dEN were more similar to each other than they 
were to the dME or HUES64, which was surprising given that the dME and dEN proceed 	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through a similar mesendoderm intermediate (Figure 2.2). When associating regions that gained 
H3K4me1 during differentiation with gene expression profiles of primary tissues, gain of 
H3K4me1 in the dEC was associated with cortex and fetal brain categories, while gain in dME 
was associated with heart and thyroid categories. Examining the dEN associations unexpectedly 
revealed that regions were associated with pancreatic islets, as well as brain-related categories 
such as cortex and fetal brain (Figure 4.1).  
A GO term analysis of regions that gained H3K27ac during differentiation again returned 
expected gene categories for dEC (e.g. neural precursor maintenance, midbrain development and 
cerebellum morphogenesis) and dME (e.g. cardiac ventricle development, vasculogenesis and 
heart morphogenesis) (Figure 5.1). Remarkably, our analysis of dEN-associated GO terms 
returned neural tube development, dorsal spinal cord development and neuron differentiation, 
though the category significance did not completely overlap with the dEC, suggesting different 
gene sets were correlated epigenetic remodeling.  
We also detected enrichment of retinoic acid signaling regulatory elements in the dEN, 
which is a signaling pathway associated with later stages of endoderm development. This 
suggests that either these regions are being remodeled to a euchromatic state in anticipation for 
their active role in later stages of differentiation or they are promiscuous and additionally 
employed in TGFβ and WNT signaling cascades. Examination of TF motifs that exhibited gain 
of H3K27ac during differentiation also revealed trends that correlated with the RNA-Seq and 
H3K4me1 analysis (Figure 5.2). There were few motifs that exhibited gain in both dEC and 
dEN, but not dME, though one notable example included the FOXA2 motif. This TF is 
historically associated with endoderm development and has recently been implicated in efficient 	 ﾠ 68	 ﾠ
 
Figure 5.1 GO categories enriched in regions transitioning to H3K27ac in the cell type indicated 
on the right compared to hESCs as determined by GREAT analysis. Regions gaining H3K27ac 
were split up by state of origin in hESC into repressed (none, IMR, HMR, and HK27me3), 
poised (H3K4me1/H3K27me3), and open (H3K4me3/H3K27me3, H3K4me3, and H3K4me1). 
Color code indicates multiple testing adjusted q value of category enrichment. 




Figure 5.2 TF motifs enriched in regions changing to H3K27ac in the cell type indicated on the 
right compared to hESCs. Color code indicates motif enrichment score incorporating total 
enrichment over background as well as differential expression of the corresponding transcription 
factor in the respective cell type. Regions gaining H3K27ac were split up by state of origin in 
hESC into repressed (none, IMR, HMR, HK27me3), poised (H3K4me1/H3K27me3), and open 
(H3K4me3/H3K27me3, H3K4me3, and H3K4me1). 	 ﾠ 70	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neural differentiation of hiPSCs as well [186]. This epigenetic association was expected in the 
dEN given that FOXA2 is actively expressed in this population, but its significance in the dEC 
analysis was surprising because it is not expressed until later stages of neural differentiation. 
This observation again suggests that these regions may be primed such that they are prepared for 
activation at later stages. An alternative hypothesis is that additional factors/pathways use the 
same region for regulation. Our windows of histone modification enrichment were at least 400bp 
in length; therefore, it is possible that additional factors bind in these regions. This has some 
analogy to super enhancers recently identified in mESCs, where many regulators of cellular 
identity are bound within similar regions [187].  
Altogether, the similarities between the dEC and dEN suggest that these two cell types 
may use similar gene regulatory elements during specification. They share the need for many 
transcription factors such as FOXA2, PAX6, ISL1 and NGN3, and a previous study found an 
overlap in epigenetic programs used in both neural tissues and in vitro derived β islets [188]. 
This may reveal novel regulatory elements that were previously associated with neural programs 
because an embryonic definitive endoderm population had not been extensively profiled. Our 
hypotheses regarding the role of H3K27ac in affecting expression level and splicing information 
discussed in Chapter 2 further support the idea that similar genes may be employed by each 
lineage, but differing between populations in expression level and the isoform expressed. 
Importantly, we cannot exclude the possibility that our association is due to heterogeneity in the 
dEN FACS sorted population or inappropriate specification of the definitive endoderm 
population. The underlying implication of this observation is that epigenetic profiling of in vitro 
derived populations represents a wealth of information regarding the process of human 
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5.4 Transcription Factor Binding at Repressed Loci 
  Using binding profiles of O/S/N in HUES64, we confirmed previous reports that O/S/N 
binding sites maintain local depletion of DNA methylation in hESCs [10]. As expected, OCT4 
binding sites frequently transitioned to a HMR state during differentiation towards all three 
lineages, suggesting stable silencing of the pluripotent network (Figure 3.8). Unexpectedly, we 
also identified many regions bound by O/S/N that are associated with genes that become 
expressed at later stages of development, such as DBX1, FOXA2 and ISL1. Many of these 
regions exhibited low CpG density and gained DNA methylation during differentiation toward 
the lineages that do not require expression of the associated gene (Figure 3.8).  
We also found that regions bound by O/S/N were capable of maintaining their chromatin 
state or transitioning to an active state during differentiation. This suggests that these TFs have 
multiple responsibilities in maintaining a pluripotent phenotype, including promoting an open 
chromatin structure at genomic regions to facilitate prompt activation at a later time, in addition 
to their role in positively regulating gene expression. Additional support for their association 
with chromatin structure maintenance was presented by a report that found these factors are 
commonly bound with Mediator, a protein essential for maintaining chromatin structure and 
DNA looping in mESCs [163]. 
  FOXA2 binding profiles in the endoderm also suggest that this TF has functions in 
addition to activation of transcription. We found that many regions bound by this TF were not 
expressed in the dEN but they were associated with later stages of endoderm development. This 
suggests that FOXA2 binding alone does not sufficient to lead to immediate activation in all 
contexts. In vitro evidence suggests that FOXA proteins are capable of remodeling chromatin 
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transcriptional machinery. However, it does reportedly interact with DNA-dependent protein 
kinase, which catalyzes phosphorylation of serine 283. This event is important for activation of 
FOXA2 targets [189], though phosphorylation is not required for DNA binding given that a 
S283A FOXA2 point mutation was capable of binding to DNA. These experiments therefore 
separate FOXA2’s ability to bind to DNA versus activate transcription. Protein activation via 
phosphorylation is a common mechanism responsible for regulation of various biological 
processes because this post-translational modification can alter protein structure and protein-
protein interactions [190].  
   
5.5 Epigenetic Priming 
  Among many other interesting trends within our data, we observed two prevalent lineage 
specific transitions: high DNA methylation to either H3K4me1 or H3K27me3 enrichment 
(Figures 2.9). Our lab made similar observations for H3K4 methylation during the early stages 
of reprogramming to an iPSC state, suggesting that this type of epigenetic “priming” event might 
be common to in vitro cellular transitions. It was not clear from these experiments whether these 
events reflected a regulatory mechanism that facilitates timely activation during cellular 
transitions or an in vitro artifact that indicates the absence of a critical co-factor necessary for 
complete transcriptional activation in vitro. The latter is unlikely as profiling cardiomyocytes 
during murine differentiation revealed a similar trend, in which H3K4me1 is gained prior to gene 
expression [168].    
  Our observation that regions with high DNA methylation switch to H3K27me3 
enrichment in CpG-poor regions bound by FOXA2 in the endoderm is one of the most 
interesting observations in this data set (Figure 4.4). It remains to be tested whether targeted loss 	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 ﾠ
of DNA methylation at these regions causes a default gain of H3K27me3 in the absence of 
additional co-factors due to underlying sequence context or represents a more active recruitment 
event and regulatory mechanism [82]. It was recently reported that the combination of 
H3K27me3 enrichment and a nearby nucleosome-depleted region creates sites amenable to TF 
binding [100]. Based on these results, we speculate that specific TFs, such as FOXA2, induce 
chromatin decompaction that leads to loss of DNA methylation, which represents the first step in 
the gene activation process. The subsequent gain of H3K27me3, by default or through active 
recruitment, then creates a platform for subsequent binding of additional TFs that cannot directly 
remodel a heterochromatic state, but instead function in transcription machinery assembly and 
transcriptional activation [191]. Further studies should establish the extent of “priming,” as this 
event does not lead to appreciable levels of Pol II at the AFP gene in the dEN cell type (A. 
Tsankov, personal communication), though expression is detected at the next stage of 
differentiation.   
  A comprehensive DNaseI HS mapping study also provided results supporting the basic 
idea that regulatory sites may be opened prior to their activation. DHS was profiled in multiple in 
vivo derived tissues, and at various stages of hESC differentiation. This study found that 56% of 
DNaseI HS sites found in hESCs were also detected in at least one additional differentiated 
population [3]. They observed gradual restriction of chromatin accessibility during 
differentiation, with loss being more prevalent than gain of accessibility, leading to 37% of DHS 
sites in terminally differentiated cell types also being identified in hESCs. The underlying 
implication is that a subset of the pluripotent epigenome is prepared for regulatory duty during 
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  The aforementioned study simultaneously highlights that many regions categorized as 
DHS in somatic tissues are not sensitive in hESCs, suggesting regulatory elements must acquire 
an accessible chromatin landscape at some time during differentiation. Recent exposure of the 
TET proteins suggests a mechanism that could facilitate these transitions. We have a limited 
understanding of the TET proteins and 5hmC because the ramifications associated with their 
dynamics have only recently been defined [30]. Initial efforts to study this epigenetic mechanism 
were complicated by the fact that traditional bisulfite sequencing does not distinguish between 
5mC and 5hmC [192], and affinity purification does not provide base pair resolution [193]. A 
protection-based method has now been developed and found 5hmC to be localized to DHS sites 
and enhancer elements containing low CpG density [164].  
  A study of reprogramming to an iPSC state found that 5hmC appeared prior to 
transcriptional activation of nearby genes [194], providing the first direct evidence that 5hmC 
enrichment is an intermediate step during the progressive loss of DNA methylation. This result 
was recently confirmed in part by profiling various stages of neural development [78]. An 
additional report also found that 5hmC co-localized with PRC2 binding in mESCs [195], 
suggesting 5hmC and 5mC exhibit distinct protein interaction capabilities given that 5mC is not 
found at regions enriched for H3K27me3 [63]. Lastly, 5hmC did not correlate with H3K27ac in 
hESCs, but did show a slight preference for regions enriched for H3K4me1 [164]. Collectively, 
this data, in combination with our profiling, suggests that 5hmC enrichment, as well as 
H3K4me1 and H3K27me3 enrichment, represent epigenetic remodeling in anticipation of 
transcriptional activation.  
  An elegant study in Drosophila melanogaster embryos recently demonstrated the 
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Premature or mosaic gene expression within the population prevented the rapid activation of 
specific transcripts necessary to promote development, which occurred when Pol II was 
successfully stalled at the promoter during unperturbed development. This report suggests that 
pausing of Pol II at promoters prior to their activation is an essential step in development, but 
this report made no experimental link to chromatin state. We do not detect Pol II at the AFP gene 
in the dEN cell type, suggesting this remodeling event is not sufficient for transcription initiation 
complex recruitment. We hypothesize that the gradual epigenetic remodeling of loci during 
development, may create a platform sufficient for generous Pol II accumulation that will allow 
swift activation in response to additional stimuli, faithfully orchestrating embryonic specification.   
 
5.6 Future Directions 
   Our data set provides many intriguing avenues to further explore the role of epigenetic 
regulation during lineage specification using hESCs. Further work should be focused on 
establishing the necessity of priming events that occur prior to transcriptional activation. Ectopic 
reporter constructs similar to those used to establish sequence requirements for DNA methylation 
[26] could be constructed to similarly mimic and perturb chromatin remodeling, to separate 
sequence context driven events from indirect events due to looping [197, 198]. Studying loci in 
isolation, ectopically, would allow us to investigate FOXA2 directed remodeling, at the AFP 
gene for example, without limiting the differentiation potential of the population. If the reporter 
shows decreasing methylation at FOXA2 binding sites, that suggests binding and loss of 
methylation is sequence-dependent. Mutations in the binding sites could then establish the 
sequence requirement for binding and demethylation, and subsequent gain of H3K27me3. 
Another avenue of pursuit would be the use of TAL effectors that are attached to histone 	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modifying enzymes, which can then be targeted to specific regions throughout the genome [199]. 
The combination of these two approaches will provide novel insight in to the epigenetic 
remodeling that is necessary for proper gene regulation during differentiation.   	 ﾠ
  We are interested in separating 3-dimensional architecture from direct binding given that 
multiple FOXA2 peaks are often clustered close together. This curiosity is fueled by our 
observation that the CpG methylation level at a subset of peaks does not decrease during 
differentiation, and this frequently occurs when multiple peaks are detected within close 
proximity to each other (unpublished observation). It is possible that the CpGs exhibiting 
demethylation represent the true FOXA2 binding sites, while the nearby peaks represent 
secondary peaks due to looping interactions. The alternative interpretation is that FOXA2 can 
bind regions containing methylated DNA. These two conclusions are indistinguishable in the 
current data set. It is widely believe that the ability to bind 5mC is an uncommon feature of TFs; 
therefore, understanding which TFs maintain this affinity is essential. Discovering which TFs 
can bind methylated DNA will likely reveal regulators that induce cellular transitions. In parallel, 
high throughput reporter assays may additionally confirm the regulatory potential of enhancers 
that are bound by these TFs and experience loss of DNA methylation [200].    	 ﾠ
  Inference regarding direct versus indirect binding can also be made using DNaseI HS 
data in combination with ChIP-Seq [201]. By combining TF-ChIP peaks, TF motifs and DHS 
sites, a recent study examined the correlation between these factors. Regions that lacked a DHS 
site or motif consistently exhibited lower enrichment based on ChIP-Seq, suggesting they were 
indirect sites of binding, likely crosslinked together because of close proximity in space rather 
than as a result of direct binding. DHS profiling in our cell types would therefore improve our 
ability to understand direct protein-DNA interactions, but also reveal general sites of protein-	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DNA interactions that are lineage specific. The loss of DNA methylation at many loci, including 
POU3F1 in the dEC, was not well covered in the ENCODE data, suggesting that many 
regulatory elements associated with development may currently be undisclosed.  
  Much attention has been directed towards chromosome architecture with the development 
of assays such as DNA adenine methyltransferase identification (DamID) and chromosome 
conformation capture techniques that promote an understanding of nuclear localization and 3-
dimensional genomic architecture. In DamID, the prokaryotic adenine methyltransferase dam 
was fused to Lamin B1, which is located in the nuclear envelope, which results in the appearance 
of adenine-6-methylation when the fusion protein interacts with DNA [202]. This approach gave 
way to the idea that repressed chromatin domains, such as those enriched for H3K27me3 and 
H3K9me2, were located in the nuclear periphery [202]. Hi-C was later designed to use proximity 
ligation as a means to study three-dimensional genomic architecture [203]. This approach 
captures interactions throughout the genome, but suffers in resolution, making it difficult to 
confidently make conclusions about discrete genomic interactions. 4-C takes a step back from 
Hi-C, and interrogates the chromosomal interactions of one locus [197]. These approaches would 
be useful for understanding the architecture associated with the HMR-to-H3K27me3 switch, as 
well as general nuclear reorganization that accompanies specification.  
   The mechanism by which FOXA2 induces decompaction could also be rectified by 
studies of the Tet proteins and hydroxymethylcytosine enrichment. TET1 was recently labeled as 
a Nanog interacting partner during reprogramming, and the Tet-related catalytic activity was 
shown to facilitate epigenetic priming at pluripotent loci [194]. This report also suggested the 
5hmC enrichment was detected prior to transcriptional activation, therefore defining an 
additional epigenetic modification that discerns primed loci. During differentiation, it is therefore 	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possible that FOXA2 binding recruits TET proteins to HMRs that initiates loss of DNA 
methylation. FOXA2-directed decompaction may allow TET binding based on chromatin 
accessibility, or FOXA2 may directly interact with and recruit the TET proteins. An additional 
prospective mechanism is that TET-directed oxidation to 5hmC occurs first, subsequently 
allowing FOXA2 binding. Until discovery of the role for Tet proteins in DNA demethylation, 
few studies had convincingly addressed the process by which regions containing high DNA 
methylation transition to active states during differentiation and development. 5hmC profiling in 
our system would likely provide numerous exciting observations regarding these events. 
  Given our observation that splicing causes expression of a catalytically inactive 
DNMT3B protein (DNMT3B3), we have renewed interest in the function of this protein during 
differentiation and development. The original study that reported embryonic lethality during 
embryonic development interrupted the catalytic domains, creating a catalytically inactive allele. 
Heterozygous mice appeared to develop normally, though homozygous mice exhibited slowed 
growth and neural defects at E11.5. Crossing of two heterozygous Dnmt3b null mice did not give 
rise to live homozygous pups in this study [20]. The inactive isoform is reportedly expressed in 
various transformed cell lines and at low levels in some somatic tissues [138, 204], as it is 
quickly downregulated during post-implantation development [20].  
  Dnmt3b deletion in mESCs does not inhibit self-renewal and proliferation and does not 
cause loss of DNA methylation at satellite regions during prolonged in vitro culture. 
Alternatively, deletion of both Dnmt3a and Dnmt3b in mESCs leads to global loss of DNA 
methylation, which can be restored by reintroduction of the active Dnmt3b gene, but not the 
catalytically inactive gene that is expressed in each of our differentiated populations. These 
observations suggest that DNMT3B3 may exert functions other than de novo DNA methylation 	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during embryonic development or that DNMT3B de novo activity is not required after 
gastrulation. The lethality observed in Okano et al may be the result of impaired activity that 
occurs pre-implantation when the active isoform is expressed, but the phenotype may take many 
more cell divisions to manifest, resulting in lethality at a later stage.  
  To understand regions subject to aberrant regulation due to defects in DNMT3B, we are 
currently examining recently published WGBS data from lymphoblasts of an ICF syndrome 
patient that exhibits a DNMT3B mutation [205]. This study found depletion of DNA methylation 
at centromeric satellites as expected and 42% overall reduction of DNA methylation on 
autosomes. Interestingly, regions associated with H3K36me3 and H3K79me2 over actively 
transcribed gene bodies remained highly methylated. The largest decrease in DNA methylation 
was seen at CpG poor promoters and intergenic regions associated with H3K4me1 in the WT 
patient. By further examining this data, we can begin to dissect regions that require DNMT3B 
for proper regulation and try to identify the developmental stage at which they require DNMT3B. 
Going forward, using ICF patient cell lines that exhibit deficient DNMT3B activity offers an 
excellent model system for understanding the interplay between DNA methylation and histone 
modifications.  
  While we cannot confirm that the remodeling observed in our system occurs in vivo, 
understanding the epigenetic remodeling that facilitates specification can likely improve efforts 
to produce functional tissues in vitro. Many current in vitro differentiation protocols produce cell 
types that appear to be in a premature state [132, 206]. Our observations suggest that a cell type 
exhibits epigenetic remodeling that forecasts the transcriptional activation destined to occur at 
later stages (e.g. AFP). Similarly, understanding the chromatin state at multiple regulatory 
elements (e.g. NODAL) required for gene activation is important for understanding a 	 ﾠ 80	 ﾠ
population’s potential. Therefore, comparing the epigenetic landscape of immature cells 
produced in vitro to primary tissues, may provide regulatory insight that will aid in the 
production of therapeutically relevant cell types in vitro.  
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6.1 Cell Culture 
  All in vitro derived cell types were derived from HUES64 [129]. Human embryonic stem 
cells were expanded on murine embryonic fibroblasts (Global Stem) in KO-DMEM (Life 
Technologies) containing 20% Knockout serum replace (Life Technologies) and FGF2 (10 
ng/mL) (Millipore). Cultures were passaged by enzymatic dissociation using Collagenase IV 
(1mg/mL) (Life Technologies). Prior to differentiation, cells were plated on matrigel-coated 
plates (BD Biosciences) and cultured in mTeSR1 (Stem Cell Technologies) for 3 to 4 days. 
Endoderm differentiation was induced in Advanced RPMI (Invitrogen), 0.5% FBS (Hyclone), 
Activin A (100ng/mL) (R&D) and WNT3A (50 ng/mL) (R&D). HUES64- derived hepatoblasts 
(dHep) were induced by culturing day 5 endoderm in RPMI media containing B27(1X), FGF2 
(10ng/mL)(Millipore) and BMP4(20ng/mL)(R&D) for five days, and collected after 10 days 
total of differentiation. Hepatocyte-like cells were derived by culturing the HUES64-derived 
hepatoblasts in Lonza hepatocyte culture media containing 10ng/mL of HGF (R&D) for 5 
additional days, or 15 days total. Mesoderm differentiation was induced by the addition of media 
consisting of in DMEM/F12 (Life Technologies), 0.5% FBS (Hyclone), Activin A (100ng/mL) 
(R&D)  (for the first 24 hours only), BMP4 (100ng/mL) (R&D), VEGF (100ng/mL) (R&D) and 
FGF2 (20ng/mL) (Millipore). To induce osteoblast differentiation, the day 5 mesoderm 
population was dissociated with accutase and replacted on matrigel coated plates (BD) in EGM-2 
media (Lonza) for 7 days, or 12 days total.  Ectoderm differentiation was induced using A83-01 
(2um) (Tocris), PNU 74654 (2um) (Tocris) and Dorsomorphin (2um) (Tocris), DMEM/F12 (Life 
Technologies) containing 15% Knock serum replacer (Life Technologies). Neurectoderm 
differentiation was induced by switching the day 5 ectoderm population to media containing 3 
µM CHIR99021 (TOCRIS), 10 µM SU5402 (TOCRIS), and 10 µM DAPT (TOCRIS), and 	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collected after 6 more days, or 11 days total. N2-supplement (Life Technologies) was added to 
cells in 25% increments every other day beginning four days after the initiation of ectoderm 
differentiation. For all cell types, media was changed daily.         
 
6.2 NanoString Analysis 
  The same probe set previously designed by our lab to interrogate regulators of 
development was employed here [129]. RNA was isolated using the Qiagen RNeasy kit. 500ng 




ChIP was performed using the following antibodies: H3K4me3 (Millipore, 07-473, Lot 
DAM1623866), H3K27ac (Abcam, ab4729, Lot 509313), H3K27me3 (Millipore, 07-449, Lot 
DAM1514011), H3K36me3 (Abcam, ab9050, Lot 499302), H3K4me1 (Abcam, ab8895, Lot 
659352), H3K9me3 (Abcam, ab8898, Lot 484088), POU5F1 (Abcam, ab19857), SOX2 (Santa 
Cruz, sc-17320X), NANOG (R&D, AF1997) and FOXA2 (R&D, AF2400). 
For live cell FACS isolation, cells were stained for 30 minutes on ice with the following 
antibodies directed towards extracellular surface proteins: CD326-PerCP-Cy5 (clone EBA1) (BD 
Biosciences), CD56-PE (clone NCAM16.2) (BD Biosciences), and CD184-PE-Cy5 (clone 
12G5) (BD Biosciences).  
Immunostaining was done with the following primary antibodies: FOXA2 (R&D, 
AF2400), GATA2 (Santa Cruz, sc-16044) SOX17 (R&D, AF1924), PAX6 (Covance, PRB-
278P) and HNF4α (abcam, ab41989). Cells were fixed in 4% Formaldehyde, incubated in 	 ﾠ 84	 ﾠ
primary antibody overnight at 4°C, and then incubated in secondary antibody for 1 hr at room 
temperature. DNA was detected using Hoechst 33342 trihydrochloride trihydrate (Invitrogen).  
 
6.4 FACS Analysis 
FACS was done on a BD FACSAria™ II using linear FSC and SSC scaling, followed by 
height and width-based doublet discrimination. The viability of the populations was assessed by 
Propidium Iodide staining, with the positively stained populations being excluded from the 
sorting gates. Compensation was calculated using FACS Diva autocompensation algorithms, and 
supplemented by manual compensation to correct for autofluorescence. Antibodies were used as 
described in the main text. 
 
6.5 WGBS-related Protocols 
Genomic DNA isolation 
Flash-frozen human tissues or cell pellets were lysed at 55°C overnight in 300-600 µl 
lysis buffer (10 mM Tris-HCl pH 8.0, 10 mM EDTA, 10 mM NaCl and 0.5% wt/vol SDS) 
supplemented with 50 ng/µl DNase-free RNase (Roche) and 1 µg/µl proteinase K (NEB). After 
extraction with an equal volume of phenol:chlorofom:isopropanol alcohol (25:24:1; Invitrogen) 
and addition of 0.5 µl (20 µg/µl) glycogen (Roche) and 1/20 vol 5 M NaCl, DNA was 
precipitated with 2.5 vol ethanol, spun down (30 min/16,000 g) at 4°C and washed with 70% 
ethanol. DNA was re-suspended in 30-100 µl of TE buffer (10 mM Tris-HCl pH 8.0, 1 mM 
EDTA) and quantified using a Qubit fluorometer and a dsDNA BR Assay Kit (Life 
Technologies). 
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WGBS Library Construction  
Genomic DNA (1-5 µg) was fragmented to 100-500 bp using a Covaris S2 sonicator 9 
times for 60 s at duty cycle 20%, intensity 5 and 200 cycles per burst. DNA fragments were 
cleaned up using a QIAGEN PCR purification kit. End-repair reactions (100 µl) contained 1x T4 
DNA ligase buffer (NEB), ATP, 0.4 mM dNTPs, 15 units T4 DNA polymerase, 5 unites Klenow 
DNA polymerase, 50 units T4 polynucleotide kinase (all NEB) and were incubated for 30 min. at 
19°C and 15 min. For some libraries we used a dCTP-free dNTP mix instead of all four dNTPs 
during for the end-repair to avoid artificially unmethylated sites. Adenylation was performed for 
30 min. at 37°C in 50 µl 1x Klenow buffer containing 0.2 mM dATP and 15 units Klenow exo
- 
(NEB). Adenylated DNA fragments and methylated paired-end adapters (purchased from 
ATDBio) were incubated overnight at 16°C in a 50 µl reaction containing 5,000 units 
concentrated T4 DNA ligase (NEB) and 3 µM of adapters. Each enzymatic reaction was 
terminated and cleaned-up by phenol/chloroform extraction and ethanol precipitation as 
described above.  
To determine unmethylated cytosine conversion rates and methylated cytosine over-
conversion rates by sodium bisulfite treatment, adapter-ligated fully methylated and fully 
unmethylated internal control DNA fragments, were spiked into WGBS library preparation at a 
molar ratio (spike-in to WGBS library) of 1:16,000 each. Adapter-ligated DNA of 270-370 bp, 
corresponding to DNA insert sizes of 150-250 bp, was size-selected on a 2.5% Nusieve (3:1) 
agarose gel (Lonza). Two consecutive bisulfite conversions were performed with an EpiTect 
Bisulfite Kit (QIAGEN) following the protocol specified for DNA isolated from FFPE tissue 
samples. One of 40 µl bisulfite-converted DNA was used in each of four 10-µl reactions to 
determine the minimal PCR cycle number for library amplification. PCR reactions contained 0.5 	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 ﾠ
U of PfuTurboCx Hotstart DNA polymerase (Agilent technologies), 1 µl of 10x PCR buffer, 250 
µM dNTPs, 1.5 µM of Primer 1.0 and 2.0 (Illumina). The thermocycling profile was 2 min. at 
95°C followed by 5-15 cycles of 30 s at 95°C, 30 s at 65°C, 1 min. at 72°C, and a final 7-min. 
extension at 72°C. Preparative library amplification using the empirically determined number of 
PCR cycles was performed in eight 25-µl aliquots, each containing 3 µl of bisulfite-converted 
DNA, 1.25 U of PfuTurboCx Hotstart DNA polymerase, 2.5 µl of 10x PCR buffer, 250 µM of 
dNTP, 1.5 µM of Primer 1.0 and 2.0. PCR products were pooled and purified twice using 
Agencourt AMPure XP SPRI Beads (Beckman Coulter) as per the manufacturer’s instructions. 
The final library DNA was quantified using a Qubit fluorometer and a Quant-iT dsDNA HS Kit 
(Invitrogen). The insert size was checked on a 4-20% non-denaturing polyacrylamide gel (Bio-
Rad). Paired-end sequencing with 100 base reads was performed on an Illumina Hiseq 2000 
followed the manufacturer’s guidelines.  	 ﾠ
 
WGBS Data Processing and Analysis 
WGBS raw sequencing reads were aligned using maq in bisulfite mode against human 
genome version hg19/GRCh37, discarding duplicate reads. DNA methylation calling was 
performed based on an extended custom software pipeline published previously for RRBS [129]. 
To ensure comparability of region DNA methylation levels across all samples, only CpGs 
covered by ≥5x in 85% of the samples qualified for the computation of region DNA methylation 
levels. To assess the DNA methylation state of various genomic regions, we resorted to our 
previously published protocol estimating a genomic region’s methylation state as the coverage 
weighted average across all CpGs within each region. Subsequently, we averaged a region’s 
DNA methylation level over replicates. Differentially methylated regions (DMRs) were defined 	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 ﾠ
as exhibiting significantly (p≤0.05, fisher’s exact test) different DNA methylation levels of at 
least 0.1.  
Many gene regulatory elements (GREs) are marked by spatially highly constrained 
reduced DNA methylation levels. It has recently been suggested that besides CpG islands, which 
are mostly unmethylated (UMR) a second class of GRE is marked by low to intermediate DNA 
methylation (IMR). We reasoned that these regions might be of particular regulatory importance 
in our system and might be missed by looking at histone modification enrichments alone. 
Therefore we adopted a similar Hidden Markov model approach as proposed in Stadler et al. to 
identify regions of reduced DNA methylation level. Briefly, we utilized a three state Hidden 
Markov Model operating on the methylation levels of each CpG in the human genome. Each 
state’s emission probabilities for the DNA methylation levels were modeled by a normal 
distribution. The model was trained on all CpGs of chromosome 19 in the HUES64 dataset using 
an adaption of the well known Baum Welch algorithm to incorporate the normal distribution 
[207].  After initial parameter estimation, we utilized the approach reported by Stadler et al. to 
determine the FDR for IMR regions and adapted the initial parameter estimates for the IMR and 
HMR states to finally 0.01(UMR), 28.8 (IMR), 81.6 (highly methylated, HMR), yielding  an 
FDR of 2%. This parameter set was subsequently used to segment all WGBS datasets. Finally, 
we used the Viterbi algorithm to compute the most probable path through each chromosome 
separately and assigned the CpG states accordingly to either unmethylated, intermediate or 
highly methylated. Subsequently, we merged neighboring CpGs residing in the same state and 
being less than 200bp apart into unmethylated, intermediate or highly methylated regions. Only 
regions harboring more than 3 CpGs were retained for subsequent analysis. The resulting region 
set is more likely to pick up DMRs due to the highly spatially constrained nature of the marked 	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 ﾠ
GRE (often 200-400bp) which easily gets masked by a coarse grained tiling based approach. The 
HMM inference framework was implemented as custom software in python (http://python.org/) 
and extended to incorporate other state distribution types. To determine differentially methylated 
regions between two samples, we followed our previously established protocol [129]. 
 
6.5 ChIP-related Protocols 
ChIP and ChIP-Sequencing Library Production 
Cells collected by FACS were crosslinked in 1% formaldehyde for 10 minutes at room 
temperature, with constant agitation, followed by quenching with 125mM Glycine for 5 minutes 
at room temperature with constant agitation. Nuclei were isolated and chromatin was sheared 
using Branson sonifier until the majority of DNA was in the range of 200-700 base pairs. 
Chromatin was incubated with antibody overnight at 4°C, with constant agitation.  
Co-immunoprecipitation of antibody-protein complexes was completed using Protein A 
or Protein G Dynabeads for 1 hour 4°C, with constant agitation. ChIPs were completed using 
previously reported methods [144]. Sequencing library production details can be found in the 
Supplemental Experimental Procedures. Sequencing libraries were submitted for sequencing on 
the Illumina Hiseq 2000.   
Immunoprecipitated DNA was end repaired using the End-It DNA End-Repair Kit 
(Epicentre), extended using a Klenow fragment (3’-5’ exo)(NEB), and ligated to sequencing 
adapter oligos (Illumina). Each library was then PCR-amplified using PFU Ultra II Hotstart 
Master Mix (Agilent), and a size range of 300-600 was selected for sequencing.  
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ChIP-Bisulfite Sequencing Library Construction  
DNA was first subjected to end-repair in a 30-µl reaction containing 6 units T4 DNA 
polymerase, 2.5 units DNA Polymerase I (Large Klenow Fragment), 20 units T4 Polynucleotide 
Kinase (all New England Biolabs), dATP, dCTP, dGTP, and dTTP (0.125 mM each), and 1× T4 
Ligase buffer with ATP for 30 min at 20°C. DNA was then adenylated in a 20-µl reaction 
containing 10 units Klenow Fragment (3′→5′ exo-) (New England Biolabs), 0.5 mM dATP and 
1× NEB buffer 2 for 30 min at 37°C. DNA was then ligated to preannealed Illumina genomic 
DNA adapters containing 5-methylcytosine instead of cytosine (ATDBio) using T4 DNA ligase 
(New England Biolabs).  
Adapter-ligated DNA fragments were subsequently purified by phenol extraction and 
ethanol precipitation and size-selected on gel. 50 ng sheared and dephosphorylated Escherichia 
coli K12 genomic DNA was added to adapter-ligated DNA as carrier during size-selection and 
bisulfite conversion. DNA was run on 2.5% Nusieve 3:1 Agarose (Lonza) gels. Lanes containing 
marker (50 bp ladder; New England Biolabs) were stained with SYBR Green (Invitrogen), and 
size regions to be excised were marked with toothpicks and adapter-ligated DNA fragments from 
200–400 and 400–550 bp were excised. DNA was isolated from gel using the MinElute Gel 
Extraction kit (QIAGEN). The low and high libraries were kept separate in subsequent steps. 
Adapter-ligated and size-selected DNA was subjected to two subsequent 5-h bisulfite 
treatments using the EpiTect Bisulfite kit (QIAGEN) following the manufacturer's protocol for 
DNA isolated from FFPE tissue samples. PCR amplification was done with 1.25 units Pfu Turbo 
Cx Hotstart DNA Polymerase (Stratagene), primer LPX 1.1 and 2.1 (0.3 µM each), dNTPs (0.25 
mM each), 1× Turbo Cx buffer. Amplified libraries were purified with the MinElute PCR 	 ﾠ 90	 ﾠ
Purification kit (QIAGEN) and subsequently purified from gel essentially as described above; 
whole gels were stained with SYBR Green, and no carrier DNA was added. Final libraries were 
analyzed on analytical 4%–20% TBE Criterion precast gels (BioRad), and measured by Quant-iT 
dsDNA HS Assays (Invitrogen).  
 
ChIP-Seq Data Processing and Analysis  
  ChIP-Seq data was aligned to the hg19/GRCh37 reference genome using bwa version  
0.5.7 [208] with default parameter settings. Subsequently, reads were filtered for duplicates and 
extended by 200bp. Visualization of read count data was performed by converting raw bam files 
to .tdf files using IGV tools [209] and normalizing to 1 million reads. 
In order to identify regions enriched for chromatin modifications we employed a two step 
approach, first identifying all regions enriched for any chromatin modification. Next, using this 
comparatively small region set, we determined the quantitative enrichment level as well as 
significance of enrichment using a Poisson background model based on the whole cell extract 
(WCE). Finally, we utilize conservative enrichment and significance cutoffs to binarize our 
enrichment signal in order to increase robustness and simplify subsequent analysis. 
First, we segmented the genome into non-overlapping windows and classified each 
window into either enriched or not enriched. This analysis was conducted separately for two 
groups, 1; H3K27ac, H3K4me3, using 200bp windows and 2; H3K27me3, H3K9me3, K3K4me1 
using 400bp windows. To compute the enrichment statistics on the window level, we determined 
the number of unique insert size extended sequence tags whose midpoint was located within the 
window of interest for the ChIP-Seq track of interest as well as the WCE. Next, we used the 
Poisson model proposed in Mikkelsen et al 2012, to determine nominal p-value of enrichment 	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 ﾠ
and computed the enrichment over the WCE. Only windows enriched at a significance level 
below p< 10
-5 and an enrichment above background greater than 3 was retained. For most 
enrichment analysis we employed only the replicate with the strongest signal. 
Next, enriched windows within a distance of 850bp were merged into larger regions. 
Regions smaller than 400bp (600bp for broad marks) after merging were discarded as due to 
noise and regions greater than 10kb were split. This procedure was carried out for three groups 
of histone ChIP-Seq tracks separately: H3K4me3 &H3K27ac, H3K4me1 and H3K27me3 & 
H3K9me3 across all 4 cell types. The resulting three lists of enriched regions were then merged 
in a hierarchical fashion: first regions identified based on H3K4me3&H3K27ac and H3K4me1, 
retaining all H3K4me3 & H3K27ac regions but merging or splitting enriched H3K4me1 regions.   
After completion of this initial processing step, regions were again filtered for minimal 
size discarding regions smaller than 400bp. Next, the same procedure was repeated for the new 
H3K4me3, H3K27ac, H3K4me1 region set and the H3K27me3, H3K9me3 region list. Finally, 
the resulting list was merged with the regions classified as UMRs and IMRs, adding only regions 
not overlapping with any region identified so far. This procedure gave rise to the region catalog 
used in subsequent analysis. 
In the second processing step, comparative analysis of ChIP-Seq experiments and 
assignment of chromatin states was carried out, excluding regions enriched for H3K9me3 only. 
First, for each region in the region catalog the significance and enrichment over WCE was 
determined using Poisson statistics applied to the duplicate filtered and insert size extended 
sequencing tag counts overlapping each identified region. Regions with tag counts deviating at a 
significance level of p<0.001 from the WCE and exhibiting enrichment over WCE ≥3 were 
classified as enriched. We chose these moderately stringent thresholds in order also pick up 	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 ﾠ
chromatin state changes that occur only in a subset of the investigated cell population and 
therefore have lower signal. However, this comes at the expense of a higher false positive rate. 
Next, we compared the enrichment levels for all four cell types (hESC, dEC, dME, dEN) for 
each epitope separately. To that end we used the Poisson model based approach proposed in and 
defined regions deviating by ≥3 fold at a significance level of p ≤0.05 as being different. Next, 
we reconciled these differential enrichment calls with our enrichment over background 
classification. Since in our setting we were mostly concerned with incorrectly called differences 
between cell states (false positives) due to heterogeneity in the distinct populations and varying 
ChIP-Seq library complexity, we redefined regions that were classified as enriched in hESC and 
not enriched in one of the differentiated cell types but exhibiting no significant difference 
according to our differential analysis as being enriched in the differentiated cell type under study. 
This approach yields a lower false positive rate in terms of dynamics at the expense of a higher 
false negative rate. However, at this point it still remains to be determined what magnitudes of 
differences in chromatin modifications are actually meaningful. In this sense, our binary 
classification approach is rather conservative and relies on previously established observations. 
Subsequently, we classified each genomic region identified in this way into one of 11 epigenetic 
states based on the binary classification of enrichment levels for the various modifications. DNA 
methylation levels were not taken into account when histone modification based states were 
assigned. Only states devoid of significant enrichment for one of the histone modifications were 
classified based on DNA methylation levels. Genomic regions were associated with their nearest 
RefSeq gene using the R package ChIPpeakAnno [210] and classified into promoter, intragenic, 
distal (<50kb from TSS and not promoter) and intergenic.  
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TF ChIP-Seq Analysis 
For OCT4, SOX2, NANOG and FOXA2 aligned read files were processed with macs 
version 1.4 [211] using the following parameters: -g 2.7e9 --tsize=36 --pvalue=1e-5 --keep-
dup=1 and the HUES64 WCE as input control. All other parameters were left at their default 
setting. For our 25bp libraries, tsize was set to 25. FDR was calculated using macs built in 
function essentially comparing the original read count distribution with a randomly shuffled 
distribution. Following this initial peak calling, only peaks significant at an FDR of 0.05 and 
present in both replicates were retained. As a second replicate for our OCT4 ChIP-Seq 
experiment we took advantage of publically available OCT4 data [212]. 
 
ChIP Bisulfite Sequencing Analysis 
For the FOXA2 ChIP-bisulfite sequencing experiment, the bisulfite treated ChIP library 
was processed similarly to the WGBS processing described above and subsequently overlaid 
with the peak calling results from the FOXA2-ChIP-Seq library that was not bisulfite treated.  
 
Motif Analysis 
Predefined sets of genomic regions were scanned for occurrences of motifs contained in 
the Transfac professional database (2009) using the FIMO program from the MEME suite [213]. 
Only motifs with at least one known associated human transcription factor and detected at a 
significance level of p≤10
-5 were used for further analysis. Next, the total number of occurrences 
was calculated for each motif. To correct for sequence composition, we trained a Hidden Markov 
Model on each set of input sequence sets and generated 10 sets of number and size matched 
region sets using the inferred probabilities as controls. Subsequently, these sequence sets were 	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also subjected to the same motif identification procedure and motif enrichment results were 
averaged over the 10 control runs. We defined the final motif enrichment score as the fraction of 
total motif occurrences in the region set of interest and the total number of motif occurrences in 
the averaged control region set. To determine differentially enriched motifs between region sets 
from different hESC-derived cell types, we calculated the fraction of motif scores between the 
two conditions, retaining only motifs with a differential enrichment ≥1.2. 
For the H3K27ac motif analysis, we computed overall motif enrichment scores for each 
region class separately as described above. Next, we correlated the motif enrichment scores only 
focusing on those motifs with scores ≥1.2. To that end we multiplied the motif enrichment score 
for the cell type of interest with the log2 fold change of the associated transcription factor in that 
cell type, giving rise to a new combined motif score. If multiple TFs mapped to one motif, we 
took the average motif score.  
For the H3K4me1 analysis, we wanted to focus on all potential TFBS gaining H3K4me1 
and not only those that also become expressed as in the H3K27ac analysis. First, we again 
determined the motif enrichment scores over background. To focus on motifs differentially 
enriched between the different cell types, we subtracted the mean motif enrichment across the 
differentiated cell types for each motif separately from the enrichment level and rank ordered the 
motifs.  
For the analysis of potential upstream regulators of transcription factors that exhibit 
changes in their promoter region, we first scanned all distal and proximal regions associated with 
these transcription factor genes for motif occurrences. Next, we determined whether any of the 
observed motifs were associated with transcription factors differentially expressed in any of the 
cell types and correlated the sign of the differential expression in each cell type with the sign of 	 ﾠ 95	 ﾠ
the epigenetic state change of the region the motif occurred in (gain of open chromatin mark: +1, 
loss of open chromatin mark or acquisition of a repressive state: -1). Next, we rank ordered all 
observed TF motifs that were differentially expressed in at least one of the cell types based on 
their occurrence/epigenetic state change correlation for each cell type separately and reported the 
gene expression levels of top 30 motifs for each cell type. 
 
6.6 RNA-Seq Related Protocols 
RNA-Seq Library Generation 
Polyadenylated RNA was isolated using Oligo dT beads (Invitrogen). The Poly-A fraction was 
then fragmented to 200–600 base pairs and then ligated to RNA adaptors using T4 RNA Ligase 
(NEB), preserving strand of origin information. cDNA was then reverse transcribed using a 
universal primer that annealed to the RNA adaptor. Then RNA was degraded, and the cDNA was 
ligated to a DNA adaptor. Final library amplification was done using bar-coded primers that 
annealed to this DNA adaptor.  
 
RNA-Seq Data Processing and Differential Expression analysis  
Strand specific libraries were constructed as described in the main text using a strand 
specific method [214]. Reads were mapped to the human genome (hg19) using TopHat v2.0.6 
[215] (http://tophat.cbcb.umd.edu) with the following options: “—library-type firststrand” and 
“—transcriptome-index” with a TopHat transcript index built from RefSeq. Transcript 
expression was estimated with an improved version of Cuffdiff 2 [135] 
(http://cufflinks.cbcb.umd.edu).  Cuffdiff was run with the following options: “—min-reps-for-
js-test 2 –dispersion-method per-condition” against the UCSC iGenomes GTF file from Illumina 	 ﾠ 96	 ﾠ
(available at http://cufflinks.cbcb.umd.edu/igenomes.html). The workflow used to analyze the 
data is described in detail in [216] (alternate protocol B).   
 
 
















S1. Multidimensional scaling of populations included in the differentiation time course. 
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S2. Characterization of the Differentiated Populations. Median Nanostring expression values 




S3.	 ﾠRepresentative FACS plots used to isolate differentiated populations. Square boxes (left and 
middle panels) and line (in right panel) indicate population collected for further analysis. 
Approximate percent of population collected is given. 	 ﾠ 99	 ﾠ
 
S4.	 ﾠAverage Nanostring expression values (log2) of unsorted ectoderm versus 
CD56high/CD326low sorted dEC cells. Immunofluorescent staining of SOX17 and PAX6 in day 





S5.	 ﾠDNA Methylation Dynamics at POU5F1 and Regions Associated with TF Binding, Related 
to Figure 3(A) Gain of DNA methylation at the POU5F1 locus (chr6:31,135,410-31,141,237). 
NANOG, OCT4, SOX2 ChIP-seq tracks (hESCs only) and DNA methylation levels in hESCs 
and differentiated cell types. Individual CpG methylation values across the locus are displayed 
using the IGV. The heatmap below shows the DNA methylation values of individual CpGs 
within the gray region. The average DNA methylation value for the entire highlighted region is 
shown on the right in red. The TSS is indicated by the arrow. Gain of DNA methylation is seen 
at the distal enhancer, as well as over the TSS, in all three differentiated cell types. 	 ﾠ 100	 ﾠ
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S6.	 ﾠNormalized motif enrichment scores for the top 15 motifs enriched in regions specifically 
transitioning to H3K4me1 in the differentiated cell type indicated on the bottom. Motif 
highlighted in green corresponds to a TF that is upregulated at the next stage (hepatoblast) of 
endoderm differentiation, whereas motifs highlighted in red are specifically upregulated in dEN 










S7.	 ﾠFraction of regions gaining H3K27me3 in dEN and being enriched for H3K27ac in human 
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